Next Article in Journal
The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
Next Article in Special Issue
Proteomic Profiling of Two Distinct Populations of Extracellular Vesicles Isolated from Human Seminal Plasma
Previous Article in Journal
Proteomic Characterization of Urinary Extracellular Vesicles from Kidney-Transplanted Patients Treated with Calcineurin Inhibitors
Previous Article in Special Issue
Emerging Role of Extracellular Vesicles in Embryo–Maternal Communication throughout Implantation Processes
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 21
Issue 20
10.3390/ijms21207568
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Tetraspanins, More than Markers of Extracellular Vesicles in Reproduction

by
Jana Jankovičová
,
Petra Sečová
,
Katarína Michalková
and
Jana Antalíková
*
Laboratory of Reproductive Physiology, Institute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, 84005 Bratislava, Slovakia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(20), 7568; https://doi.org/10.3390/ijms21207568
Submission received: 21 September 2020 / Revised: 8 October 2020 / Accepted: 8 October 2020 / Published: 14 October 2020
(This article belongs to the Special Issue Extracellular Vesicles in Reproduction)
Browse Figures
Versions Notes

Abstract

:
The participation of extracellular vesicles in many cellular processes, including reproduction, is unquestionable. Although currently, the tetraspanin proteins found in extracellular vesicles are mostly applied as markers, increasing evidence points to their role in extracellular vesicle biogenesis, cargo selection, cell targeting, and cell uptake under both physiological and pathological conditions. In this review, we bring other insight into the involvement of tetraspanin proteins in extracellular vesicle physiology in mammalian reproduction. We provide knowledge regarding the involvement of extracellular vesicle tetraspanins in these processes in somatic cells. Furthermore, we discuss the future direction towards an understanding of their functions in the tissues and fluids of the mammalian reproductive system in gamete maturation, fertilization, and embryo development; their involvement in mutual cell contact and communication in their complexity.

Graphical Abstract

1. Introduction

Extracellular vesicles (EVs) are small membrane-derived particles released from cells into the extracellular space. The EV environment ensures the protection of cargo from enzymatic degradation during transit through the extracellular space [1,2,3]. EVs are released by most cell types under both normal and pathological conditions [4], and their presence has been observed in many body fluids [5,6,7]. It is known that the formation of extracellular vesicles is a precisely regulated process [8]. Based on published data, the term EVs denotes a population of different groups of vesicles classified according to their biogenesis and release pathway, evidently overlapping in some cases. Individual membrane vesicle categories differ, not only in origin, size, and morphology, but also in content [4] (Figure 1). The currently known data regarding the molecular cargo of extracellular vesicles (lipids, RNAs, and proteins) are summarized in the ExoCarta database [9,10,11] and in Vesiclepedia, a compendium for EVs [12,13]. Based on their diameter, EVs can be classified into several groups, namely, ectosomes, or shedding microvesicles (MVs) (100–1000 nm) [14,15,16]; exosomes (EXs) (30–100 nm) [15]; apoptotic bodies (ABs) (50–5000 nm) [17,18]; and other EV subsets, as reported by Shah et al. [19]. These groups of extracellular vesicles also differ in their origin [8]. Exosomes have an endocytic origin and are released from multivesicular endosomes. The biogenesis of EXs begins with the internalization of molecules via endocytosis [20]. Subsequently, endocytosed molecules are either recycled to the plasma membrane or trafficked to multivesicular bodies [4]. Multivesicular bodies fuse with the plasma membrane, leading to the release of intraluminal vesicles as exosomes into the extracellular microenvironment [21]. Whereas, MVs are formed by blebbing of the plasma membrane and subsequent fission of the membrane blebs [4,22], ABs are shed from the membrane of cells during the process of programmed cell death or apoptosis [4,18].
While it is generally accepted that the main function of EVs is the mediation of intercellular communication [23,24,25], they are also involved in cell homeostasis, coagulation, and waste management [22]. Although cells typically release several major EV populations defined by biophysical properties and biological functions, the heterogeneity among them is obvious and likely underlies the specific role of EV subpopulations in individual cellular processes [26]. EVs are effective intercellular transporters of proteins, lipids, and nucleic acids. The protein cargo of extracellular vesicles includes proteins participating in cell adhesion (integrins, ICAM (intracellular adhesion molecule)), intracellular trafficking (GTPases, RAB (proteins included in regulation of endocytosis and secretory processes, annexins), and signal transduction (protein kinases, G proteins, β catenin) [27]. EVs are usually enriched in tetraspanin proteins (mainly CD9, CD63, and CD81) and other proteins, such as ALIX (protein regulating cellular mechanisms), TSG101 (tumor susceptibility gene 101 protein), MHC1 (major histocompatibility complex 1), and HSP90 (heat shock protein 90) [28,29]. Regarding lipids, EVs are characterized by the presence of phosphatidylserine, cholesterol, sphingomyelins, and ceramides [30,31], which participate not only in intercellular signaling, but also ensure structural stability [32]. EVs may also carry nucleic acids (genomic DNA, mitochondrial DNA, mRNA, miRNA, and long non-coding RNA) [33]. Overall, EVs can alter the physiological and pathological function of recipient and parent cells through the transfer of proteins, lipids, and RNA [34]. Exosome uptake (and likely uptake of the other types of EVs) can cause activation, differentiation, or dedifferentiation of target cells depending on the delivered cargo [35]. Notably, it was shown that exosomal mRNA transferred to recipient cells can be translated and that miRNA may regulate gene expression in recipient cells [33]. Beside the somatic (body) systems, many tissues and cells of the reproductive tract release EVs, which are believed to participate in various steps of the reproduction process (reviewed in Reference [36]). The participation of tetraspanin family proteins, the most prevalent proteins in EVs [37,38,39], which are routinely used only as markers (mostly for exosomes) in mammalian fertilization, has been demonstrated [40,41,42]. In this review, we focus on current knowledge regarding EV tetraspanins, regarding reproduction, and their demonstrated or predicted function.

2. Tetraspanin Family Proteins

In mammals, the tetraspanin protein family includes more than 30 members (Table 1), and tetraspanins have been found on the plasma membrane or in endosomal or lysosomal compartments of almost all cell types [43]. The tetraspanin family includes distinct proteins characterized by their common specific molecular structure (Figure 2), represented by four transmembrane domains containing conserved polar residues; a small extracellular loop (SEL) and large extracellular loop (LEL) with 4, 6, 7 or 8 conserved cysteine residues; and short cytoplasmic tails [44,45,46,47,48]. Polar residues stabilize the tertiary structure [49]. Tetraspanins are usually post-translationally modified by glycosylation in extracellular domains and palmitoylation at intracellular cysteines [43]. They also contain a tyrosine-based sorting motif for intracellular compartment targeting that may mediate internalization via associated proteins [50]. Tetraspanins are generally accepted to have an important role as organizers of each other and of distinct transmembrane and cytosolic proteins (integrins, members of the immunoglobulin superfamily, proteases) into a multimolecular membrane network called the tetraspanin web [48,51,52,53,54]. Association with proteins and lipids results in the organization of specific microdomains located in membranes that are different from lipid rafts, so-called tetraspanin-enriched microdomains (TEMs). Within the tetraspanin web, several levels of tetraspanin protein associations have been described. Through specific, lateral association, tetraspanins can create primary complexes with other non-tetraspanin proteins. Tetraspanins also possess a strong predisposition to associate with each other, which likely contributes to the assembly of a secondary interaction network in which non-tetraspanin proteins are associated via palmitoylated tetraspanins acting as linker proteins. Moreover, tetraspanins can associate with lipids (e.g., cholesterol), creating larger complexes [43]. It was shown that the constant region of the LEL is responsible for tetraspanin dimerization, while the variable region is responsible for the association with non-tetraspanin partners [49]. In general, tetraspanins are implicated in many cellular processes, such as cell adhesion [55], regulation of cell motility, and/or morphology, fusion, signaling, and other functions [52,56,57,58,59]. Increasing evidence points to their pivotal role in the pathogenesis of viral, bacterial, parasitic, and fungal infections (reviewed in References [60,61,62]) and in cancer (reviewed in References [63,64]). Moreover, it was shown that tetraspanins are important, if not essential, in mammalian fertilization [40,41,42].

3. Tetraspanins and Other Proteins in Extracellular Vesicles (EV Tetraspanin Network?)

Because of the high content of tetraspanins, such as CD9, CD81, CD63, and CD82, in EXs, they are most often used as specific exosome markers [65,66,67]. However, since tetraspanin expression has also been detected on cell surfaces, they may be a part of plasma membrane-derived vesicles, such as microvesicles, directly budded from the membrane. In addition to tetraspanins (e.g., CD9, CD81, CD82, CD63, CD151, tetraspanin-6, and tetraspanin-8), EVs also possess other proteins. Willms et al. [26] reported that while MVs were found to be selectively enriched in cytoskeletal elements, cytoskeleton-associated proteins (e.g., actin, actinin, dynamin, myosins, tubulin, and VDAC1/2) and septins (along with their associated binding partners), EXs were enriched in integrins (α2, α6, β1, and β4) and other proteins (syntenin, TSG101, and ALIX). In the same study, after summarizing the extensive proteomic analysis of EXs, the authors stated that exosomes released by distinct cell types and even from the same cells can largely differ both quantitively and qualitatively in their specific tetraspanin profile. These data suggest that the unique composition of individual tetraspanins in EVs may be responsible for alterations in cellular responses.
Although several protocols and methods are used for EV isolation (differential ultracentrifugation, density gradient flotation, size exclusion chromatography, ultrafiltration, asymmetrical-flow field-flow fractionation, microfluidic isolation, flow cytometry, and immunocapture (reviewed in Reference [26])), most methods result in a fraction enriched by some population of EVs, but ‘contaminated’ by other extracellular vesicle populations, and thus, currently, there is a lack of reliable assays for isolation and characterization approaches that address EV heterogeneity. With the aim of improving research in the field of extracellular vesicles, Lozano-Andrés et al. [68] modified synthetic nanovesicles with recombinant antigenic regions of tetraspanin proteins enriched in EVs (CD9, CD81, and CD63) to provide reference material for the detection of EVs. It is important to note that tetraspanins are involved in protein biogenesis, exosome production, and vesicular cargo sorting, and thus, they significantly affect the function of vesicles.

4. Role of EV Tetraspanins in Somatic Cells

4.1. Role of Tetraspanins in EV Formation

Exosomes can be formed through ESCRT (endosomal sorting complex required for transport)-dependent or ESCRT-independent pathways (reviewed in References [29,69,70,71]). Studies by van Niel et al. [71] and Chairoungdua et al. [72] indicated that tetraspanins may be crucial players in ESCRT-independent pathways of exosome biogenesis and secretion. It is well known that tetraspanins can modulate membranes by affecting their curvature [73,74,75,76], which directly predetermines their participation in EV formation. Considering the reversed cone-like molecular shape of CD9, Umeda et al. [74] suggested that clustering of tetraspanin molecules could modulate membrane curvature to enable exosome budding and facilitate subsequent interaction of the C-terminal region of tetraspanins (cytoplasmic tail) with cytoskeletal actin through ezrin, radixin and moesin proteins [77], which may be involved in EV fission from the parent cell membrane.

4.2. Role of Tetraspanins in EV Cargo Selection, Targeting, and Uptake

Although the processes of targeting and uptake (internalization of EVs by recipient cells) are currently not fully understood, it is evident that molecules involved in tetraspanin-enriched microdomains of EVs and TEMs of recipient cells, especially tetraspanins, integrins, and other adhesion proteins, play a key role in the process of binding, fusion, and targeting of extracellular vesicles and in selective uptake of EVs by recipient cells [26].
As shown in exosomes, the internalization of membrane molecules into endosome compartments is related to the rearrangement of TEMs [78]. Based on previous findings, Rana et al. [38] hypothesized that regulation of the protein assembly of exosomes, and potentially, the recruitment of microRNA is ensured by tetraspanins. In 2012, Rana et al. [39] reported for the first time that selective exosome uptake by cells and tissues is critically dependent on the tetraspanin web composition. Therefore, it seems that TEMs are involved not only in molecular internalization and recycling, but that tetraspanin proteins (at least CD9, CD81, CD82, CD63, and tetraspanin-8) also regulate the sorting of proteins and possibly RNA to EVs (reviewed in Reference [79]). A quantitative proteomic analysis conducted by Perez-Hernandez et al. [80] showed that the TEM interaction network corresponds to 45% of the exosomal proteome. Consequently, the diminishment of the tetraspanin profile of extravesicular TEMs can result in a decrease in the concentration of some of their associated partners. In general, common components of TEMs within the cell membrane are tetraspanins, integrins, and other adhesion receptors and transmembrane receptor proteins [52,57,81,82]. Therefore, changes in the expression of specific tetraspanins may modulate selective targeting and uptake of EVs, thereby affecting the cellular response. Willms et al. [26] suggested the utilization of the tetraspanin (and integrin) profile as a distinguishing criterion for individual EV subpopulations. The involvement of tetraspanins in vesicular cargo selection was also reported in neuroblastoma cells, where EVs targeted the cells depending on the presence of CD63 tetraspanin or amyloid precursor protein [31]. The exosomal tetraspanins CD9 and CD81, together with integrin αvβ3, were shown to be involved in the targeting and uptake of exosomes by dendritic cells, and a complex of tetraspanin-8 with integrin subunit CD49d (α4) determines the selective targeting and uptake of tumor-derived exosomes by endothelial cells [83]. In a very recent study, Umeda et al. [74] revealed the cone-like molecular shape of CD9 (based on the crystal structure of CD9 and cryo-electron microscopy of human CD9) and proposed two potential roles of tetraspanins in exosome function. Tetraspanin clustering may directly affect membrane curvature and thereby enable exosome budding, or alternatively, tetraspanins can control vesicular cargo sorting through association with other partner proteins via EWI family proteins [77,84], thereby establishing a complex functional molecular network [74].
To deliver proteins or nucleic acids, EVs undergo direct fusion with the target cell membrane or the endosomal compartment membrane after endocytic uptake [85,86,87,88]. The uptake of EVs can occur through several endocytic pathways, including clathrin-dependent endocytosis and clathrin-independent pathways, such as caveolin-mediated uptake, macropinocytosis, phagocytosis, and lipid raft-mediated internalization. The same authors stated that the different uptake mechanism of individual EV populations likely depends on the proteins and glycoproteins on the surface of the vesicle and the target cell (reviewed in Reference [87]). Based on the fact that tetraspanins are involved in many cellular processes, including vesicular and cellular fusion [52,89], they are ‘predestined’ to participate in EV binding and uptake by cells (reviewed in References [90,91,92,93]). In vitro and in vivo experiments have suggested that exosomes diffuse throughout the whole body, with selective enrichment in different cells/organs depending on exosome-tetraspanin complexes and cell ligands [39]. These findings were supported by experiments on somatic cells, where a reduction in EV uptake by target/recipient cells was observed after treatment with antibodies against tetraspanin-8, CD9, CD81, and CD151 [94,95,96]. It should be noted that in some cases, a cellular response, such as activation/inhibition of signaling pathways, may be induced by EVs without their internalization, as has been illustrated in several studies [97,98,99,100,101,102]. It is generally believed that tetraspanins act as regulators of the adhesive activity of several adhesion molecules, including integrins [103,104,105,106,107,108,109], and thus, they may not only control adhesion, but may also affect signaling pathways. Therefore, specific tetraspanin and integrin profiles of EVs could ensure the specific role of individual EV subpopulations.

4.3. Role of Tetraspanins in Immunostimulatory and Immunosuppressive Properties of EV Subpopulations in Cancer

In recent years, great effort has been devoted to the elucidation of EV function in cancer biology (reviewed in References [110,111]). Numerous EVs secreted by cancer cells transport their molecular content to various target cells, including endothelial, epithelial, and immune cells, and serve as regulators of intercellular communication of cancer cells [110,112]. Increasing experimental data indicate a crucial role of EVs in cancer progression. On the other hand, several studies have suggested that non-tumoral cells may suppress cancer initiation and progression via EVs (reviewed in Reference [110]). Extracellular vesicles can participate in remodeling of the tumor microenvironment, which affects endothelial cells, epithelial cells, stromal cells, fibroblasts, and macrophages [113,114,115]. Findings regarding tetraspanins and integrins are also related to their role in organotropism, the non-random distribution of metastases in an organ-specific pattern [39,113,116]. Hoshino et al. [116] suggested that integrins in EVs mediate not only their adhesion to recipient cells, but also trigger signaling and inflammatory responses in recipient cells, thereby leading organs to become permissive for metastatic cell growth. As reported by Yue et al. [113], the communication between tumor-derived EVs and the matrix is also significantly affected by the interaction of tetraspanins (CD151 and tetraspanin-8) with integrins, and proteases. In addition, EVs can mediate hematopoietic and stromal cell activation, including (lymph) angiogenesis, and stimulate epithelial-mesenchymal transition in neighboring non-metastatic tumor cells [113].

4.4. Role of EV Tetraspanins in Antigen Presentation

Most immune system cells (likely all), including antigen-presenting cells (APCs), secrete extracellular vesicles, and depending on the type and status of the parent cell, EVs may modulate the immune response in various ways (initiation, expansion, maintenance, or silencing) [117]. Professional antigen-presenting cells mainly include dendritic cells, macrophages, and B cells. It was shown that EVs released by APCs can induce an adaptive immune response by the distribution of MHC-peptide complexes and presentation of these antigens to specific T cells ([21,118,119], as reviewed in Reference [79]). As known molecular organizers, tetraspanins present on the surface of immune cells have been shown to play an important role in the adaptive immune response via involvement in antigen presentation and formation of molecular complexes in immunological synapse assembly [89,120,121,122,123,124,125]. The interaction of the APC tetraspanins CD9, CD37, CD53, CD81, and CD82 with MHC molecules, as well as engagement of MHC-peptide complexes in TEMs, has led to the consideration of their role in the formation of MHC-II multimers and enhanced antigen presentation [122,126,127,128,129]. According to Kropshofer et al. [122], the organization of MHC-II complexes in TEMs could determine the composition of the immunological synapse, and subsequently, the quality of the T helper cell response. Andreu and Yáñez-Mó [79] suggested that in addition to regulation of the expression and sorting of MHC to EVs, tetraspanins may be responsible for the degree of MHC complex clustering in EV membranes sufficient to induce an immune response. Tetraspanins can also participate in the regulation of different steps in the immune response through their ability to alter the function of their associated partners (reviewed in Reference [117]).
The evidenced or predicted involvements of tetraspanins in EV functions in somatic cells are summarized in Figure 3.

5. Tetraspanins in EVs of the Female and Male Reproductive System

5.1. Female Reproductive System

In most animals, developing oocytes arrested in primordial ovarian follicles in meiotic prophase I are surrounded by granulosa cells and follicular fluid. From the moment of female reproductive maturity, the oocytes begin to form zona pellucida, and granulosa cells start proliferation and cumulus formation. After the resumption of meiosis, the first polar body is extruded, and the oocyte is arrested in metaphase II. The process within the follicle (called folliculogenesis) is mediated by paracrine factors from theca cells, mural and cumulus granulosa cells and the oocyte itself [130,131], and after ovulation (the process after follicle rupture when the egg is released into the oviduct), there is communication between the cumulus-oocyte complex and the oviductal epithelium. Moreover, differential secretion of oviductal proteins reflects the presence of an oocyte or spermatozoon [132]. To understand the physiological, as well as pathological events during mammalian gamete maturation, fertilization, and embryo development, it is essential to clarify the interactions of the individual components (hormones, growth factors, enzymes, and many other proteins) with gametes or the embryo upon their journey through the female reproductive tract. It has been suggested that one of the vehicles of bioactive material are EVs, but little is known about their function and molecular content, particularly regarding the role of tetraspanins, which are typically only referred to as markers of EVs.

5.1.1. EVs in Follicular Fluid

Oocyte growth and development within the follicle is completely dependent on the nourishing capacity of the granulosa cells, and communication between follicular cells and oocytes occurs via paracrine and gap-junctional signaling [133]. The highly specialized cumulus cells (CCs) have a membranous extension and transzonal projections (TZPs), which penetrate the zona pellucida (ZP) and join to the oocyte plasma membrane, forming gap junctions at the ends of TZPs and between cumulus cells. These connections are essential for molecular transfer between the oocyte and CCs and among individual cumulus cells [134]. Currently, it is known that this communication is bidirectional [134,135], and the possibility of molecular transport mediated by extracellular vesicles has been discussed in previous studies [136,137].
The presence of EVs (CD63-positive) in ovarian follicular fluid (FF) was first identified in horses by da Silveira et al. [138]. The authors documented the transfer of bioactive material through the uptake of microvesicles and exosomes from the follicular fluid by surrounding granulosa cells. Their later findings indicated a possible role of exosomes from FF in the regulation of follicle maturation [139]. CD63-positive EV-mediated cell-cell communication within the follicle was also confirmed in cattle [140] and in pigs [141]. Later, the uptake of EVs (CD63-positive) by bovine granulosa and cumulus cells was documented, and EVs were identified in cumulus cells and in transzonal projections [142]. CD63- and CD81-positive exosomes have also been isolated from human FF [143,144]. The impact of EVs on ovarian function was documented for the first time by Hung et al. [145] in cattle. The authors found that highly CD81-enriched EVs derived from small but not large bovine follicles, likely released by granulosa cells, were able to upregulate cumulus gene expression in vitro, and thus, to stimulate cumulus expansion. Based on different levels of CD81 within EVs isolated from small, medium, and large follicles, Navakanitworakul et al. [146] suggested that changes in EV biogenesis or uptake occurred during follicle development.
Interestingly, a positive effect of EVs (CD63-positive) isolated from follicular fluid on correct bovine embryo development has been observed [142].

5.1.2. Oocyte EVs

The presence of CD9-containing exosomes, such as vesicles in the perivitelline space (PVS, the space between the oolema and ZP) of mature (MII) mouse oocytes was reported by Miyado et al. [147], and the existence of a CD81-rich layer in the ZP and a CD9-rich layer in the PVS of mouse oocytes was documented by Ohnami et al. [148]. The authors stated that the CD9 layer is predominantly produced in oocytes, while the CD81 layer is predominantly produced in cumulus cells and localized to the ZP [148]. In cattle, extracellular vesicles were detected outside the TZP within the perivitelline space of oocytes, and communication of cumulus cells and oocytes via these cell-secreted vesicles was suggested [136]; later, CD9-positive structures resembling transzonal projections were observed in MII bovine oocytes [149].
Thus, it can be assumed that EVs assist in the initial stages of follicle and oocyte development and maturation.

5.1.3. Oviductal EVs

Successful maturation of a developmentally competent oocyte is followed by its release from the ovary into the oviduct, a part of the female reproductive tract that connects the ovary with the uterus and provides the opportunity for transport and contact between female and male gametes, followed by successful fertilization and early embryo development. After ovulation, the cumulus-oocyte complex (COC) passes through the fallopian tube and ampulla to the ampullary-isthmic junction, the place where contact with sperm occurs [150]; thus, the oviductal fluid is present not only during the time of ovulation, but also at the moment of sperm-egg interaction and following fertilization events. Oviductal EVs (oEVs), or ‘oviductosomes’, as they were named by Al-Dossary et al. [151], have recently been identified as potential mediators of the gamete/embryo interaction within the oviduct. They have been described in mice [151,152], cows [153,154], women [155], hens [156], bitches [157], and turtles [158]. Nakano et al. [159] reported that CD81-expressing exosomes from oviductal mesenchymal cells likely modulate the ciliogenesis of Müllerian epithelial cells in mice. CD9-positive oEVs were detected in mouse oviducts [152] and in bovine oviductal fluid secreted by oviductal epithelial cells in vivo and by these cells cultivated in vitro [154]. Interestingly, the presence of CD9-positive oEVs remained unchanged across the different stages of the cow estrous cycle [160], although proteomic analysis showed different protein profiles of in vivo and in vitro secreted EVs [154] and that their different cargo is under hormonal regulation [160]. Moreover, dissimilar concentrations and sizes of oEVs obtained from different parts of the oviduct (ampulla and isthmus) were described [161]. The isthmus is a part of the mammalian oviduct serving as a sperm reservoir (reviewed in Reference [150]), where sperm undergo their final maturation process, called capacitation, involving a series of many biochemical and physiological changes essential for the acquirement of fertilization competence (reviewed in Reference [162]). The importance of oEVs in this process was documented by Al-Dossary et al. [151], who showed not only the presence, but also the role of CD9-positive oEVs in mouse sperm acquisition of PMCA4a protein, a member of a family of Ca2+ efflux pumps essential for the hyperactivated motility and fertility of sperm. The same authors later determined the mechanism of this cargo delivery. They proposed that sperm-oEV fusion is mediated by receptor-ligand interactions of ανβ3 and α5β1 integrins in sperm and in oEVs, where CD9 acts as a scaffold for these adhesion molecules [163]. The presence of oEVs carrying and delivering PMCA4 was also documented later in humans [155].
Before the sperm reach the oviduct, they must traverse the uterus, where they meet extracellular vesicles called ‘uterosomes’ [164]. In addition to the previously mentioned PMCA4 protein from oviductosomes, the sperm can gain the same molecule together with GPI-linked SPAM1 (Sperm adhesion molecule 1) [151,164] from uterosomes (CD9-positive) during this transport.
It is known that the oviductal mucosa protects sperm against aging damage during storage within the mammalian isthmus. Moreover, the positive effect of vesicles prepared from the apical cell membranes of the oviductal epithelium on sperm viability was documented twenty years ago in rabbits [165], horses [166], and humans [167]. In avian species, the unique ability of sperm to stay in oviductal tubular crypts for a prolonged period is also known [168], but the mechanism by which the sperm are protected in sperm storage tubules (SSTs) of the hen oviduct is still not fully understood. Huang et al. [156] suggested that the high CD63 protein expression level in the SSTs may be physiologically related to the sperm storage function of the oviduct. The authors detected CD63 protein in the apical region and cytoplasm of SST cells from the control group and artificially inseminated group of hens; they observed a decreasing level of CD63 in SST cells containing sperm. The reduction in CD63 protein was not observed in SST cells without sperm, suggesting secretion of CD63-containing exosomes by SSTs into the lumen in response to resident sperm and their probable role during the storage of sperm in the oviduct [156]. Higher secretion of CD63-positive vesicles by ciliated and gland cells of oviductal epithelium at the time of sperm storage was also reported in the Chinese soft-shelled turtle Pelodiscus sinensis [158].

5.1.4. EVs of Fertilized Oocytes and Early Embryos

In addition to MII oocytes, the presence of extracellular vesicles has also been documented in the moment of fertilization in mice. Transfer of CD9-positive oocyte fragments to fertilizing spermatozoa was observed by Barraud-Lange et al. [169]. Later, Miyado et al. [147] reported contact of sperm with CD9-positive vesicles released from the oocyte PM into the PVS of oocytes and their ability to facilitate sperm-egg fusion. Similar findings were also described in hamsters. The authors suggested that the structures within the inner part of the ZP may support this transfer via the formation of a complex with CD9-positive vesicles. Interestingly, the suggestion of Miyado et al. [147] that the transfer of CD9-containing vesicles from wild-type oocytes could rescue the fertility of Cd9-deficient mice was later questioned by Gupta et al. [170] and Barraud-Lange et al. [171]. The release of CD9-positive vesicles in mice was also observed immediately after gamete fusion, when CD9 leaves the oocyte PM together with other associated proteins, and thus, likely participates in the prevention of polyspermy [172]. CD9-positive vesicles in the ZP after fertilization were documented in human zygotes [173] and in the PVS of bovine and porcine embryos [149]. Additionally, CD81-positive vesicle clusters were observed in the PVS of bovine [174] and porcine [149] embryos.

5.1.5. EVs in Later Embryo Development and Implantation

During the early post-fertilization stage, the embryo undergoes several developmental changes, such as the first cell division, activation of the embryonic genome, compaction of the morula, and formation of the blastocyst. Under physiological conditions, these processes begin in the oviduct, where the embryo spends from two to six days, depending on the species [175]. EVs produced on both sides play an important role in mutual oviduct-embryo communication, which ensures proper embryo development and subsequent implantation [176].
EVs isolated from embryonic and maternal sources have been described by several authors. In addition to the aforementioned secretion of oviductosomes [151], EV secretion by endometrium cells of the uterus has been documented in mice [164], humans [177,178], and sheep [179]. Moreover, EVs produced by embryos in vitro or in vivo have been reported in cattle [180,181] and sheep [179]; however, their study in terms of structure, protein content, and role in embryo development is difficult. At least in cattle, differences in the secretion and protein composition of EVs under in vivo and in vitro conditions have been described [154]. Nevertheless, in bovine embryos, it was shown that internalized oEVs (containing CD9) during in vitro culture improved the potential of embryos to reach the blastocyst stage and survive under in vitro conditions [153,154,161]. Similarly, in mice, EVs containing CD9 derived from donor oviductal fluid improved embryo transfer efficiency [182].
Despite the fact that a bidirectional embryo-maternal communication has been suggested in cattle [154,183,184], in humans, only the uptake of embryonal EVs (eEVs) by endometrial epithelial cells, but not by oviductal cells has been shown [185]. This could be due to the problem in distinguishing oEVs from eEVs obtained from in vivo sources (oviductal fluid and maternal plasma [186]). Moreover, the population of EVs secreted by the embryo is species-specific, and their production also differs depending on embryo production technology and embryo developmental stage [173,181,187,188].
As regards embryonal EVs in terms of tetraspanin presence, CD9-positive eEVs secreted by porcine embryos produced in vitro and their role as a tool for communication between embryos (and also within their microenvironment) in vitro was reported for the first time by Saadeldin et al. [189]. The presence of CD9- and CD63-positive EVs secreted from day 7 to 9 by in vitro cultured bovine blastocysts (both by in vitro fertilization and parthenogenetic activation derived blastocysts) was subsequently reported by Mellisho et al. [181]. The embryo-embryo cross-talk was also confirmed in bovine embryos cultured in groups [190], where vesicles (CD9- and CD63-positive) isolated from embryo-conditioned culture medium were internalized by embryonic cells and had a positive effect on blastocyst development and lowering apoptotic cell ratios. Moreover, the essentiality of EVs (CD9-positive) secreted by bovine embryos cloned using somatic cell nuclear transfer technology for their further development was also documented by Qu et al. [191]. In addition, CD81- and CD63-positive EVs from human blastocoel fluid [192] and secretion of EVs strongly positive for CD9 and CD81 and weakly positive for CD63 and CD82 by in vitro cultured bovine embryos were recently reported [193].
Under physiological conditions, the embryo leaves the oviduct and passes to the uterus, or it is inserted into the uterus after in vitro fertilization. Successful implantation occurs in the microenvironment of the uterine cavity and is influenced by several factors. After entering the uterus, the blastocyst undergoes hatching and final preparation for implantation, during which its apposition, adhesion, and invasion through the endometrial epithelium occur. An important role in the process of attachment to the endometrium is played by the trophectoderma (layer of trophoblasts), which later forms the maternal component of the placenta [178]. Production of EVs during contact of the embryo with the endometrial epithelial cells of the uterus and uterine fluids [177] was confirmed, and the importance of mutual communication through those EVs for proper implantation, placentation, further embryonic development, and thus, a normal pregnancy was reported (reviewed in Reference [175]).
In humans, CD9-, CD63- and CD81-positive EVs have been observed in uterine fluid [177,194]. As a source of EVs in the uterine cavity, endometrial epithelial cells with CD9 and CD63 on their apical surface have been detected. The intensity of CD63 staining reached a maximum in the middle secretory phase of the menstrual cycle, the time of endometrial receptivity for implantation, while CD9 expression did not change [177]. The role of CD9 as a regulator of α3, α6, and β1 integrins in association with endometrial function in embryo implantation was reported earlier by Park et al. [195]. In endometrial cell cultures, CD81 and CD151 tetraspanins were detected along with variable levels of several integrins, which are known as tetraspanin partners. While β1, α3, and α6 laminin-binding integrins were highly expressed, α2 integrins showed intermediate expression, ανβ3 integrins showed low expression levels, and α1, α5, β2, and α4 integrins showed very low or undetectable expression levels [196]. Moreover, the authors described the CD98 receptor, predominantly associated with CD9 within TEMs, as a putative determinant of endometrial receptivity during embryo implantation in humans. Overexpression of these two proteins significantly enhanced mouse blastocyst adhesion. Additional tetraspanin-14 was identified in EVs released from human endometrial epithelial cells (luminal and glandular) by Greening et al. [178]. These EVs were taken up by trophoblast cells and enhanced their adhesive capacity during implantation. The authors also considered the important role of EVs in cell-cell communication in the microenvironment of the uterus before implantation and placentation and hypothesized that EVs from a single endometrial epithelial cell could affect surrounding endometrial cells, and thus, prepare them for implantation.
In mice, the presence of CD9 in the endometrium, especially in cells surrounding early implantation sites, was documented by Wynne et al. [197]; however, according to these authors, maternal CD9 expression is not essential for successful embryo implantation or maintenance of pregnancy. According to Liu et al. [198], CD9 expressed in the endometrium acts rather as a suppressor at the invasion but not the adhesion stage of embryo implantation. On the other hand, it was suggested a supportive effect of CD9-positive EVs derived from outgrowth embryo on mouse embryonic developmental competence in vitro and implantation potential in vivo [187]. A higher blastocyst formation rate of embryos co-cultured with exosomes (CD9-, CD63-positive) and a reduction in the apoptotic rate of these embryos in pregnant mice [199] has also been documented.
Nakamura et al. [200] and later, Kusama et al. [201] focused on studying EVs in the uterine fluid in cattle. They also confirmed that the source of EVs in this fluid is not only the endometrium, but also the fetus and that these EVs are necessary for interactions between the embryo and the endometrium, particularly in the implantation process. In addition to CD63, a large number of other exosomal proteins have been identified, including ezrin and moesin [200], the connection of which with other tetraspanins (predominantly CD9) in complex protein network and vesicle formation has been recently documented [74]. Mutual maternal-embryo communication through CD63-positive EVs isolated from uterine fluid has also been observed in sheep [202].
Similarly, in pigs, the release of CD63-positive EVs by the endometrium and chorioallantoic membrane/placenta and by porcine trophectoderm cells has been documented [203,204]. Moreover, communication between the EVs secreted by the trophectoderm and internalized by endothelial cells of the endometrium and vice-versa has been hypothesized in this species, taking into account the unique epitheliochorial (non-invasive) placentation [204].
The mammalian placenta is a temporary organ consisting of fetal and maternal tissues, connecting the developing fetus to the uterine wall, with the interface mediating nutrient uptake, thermo-regulation, waste elimination, and gas exchange. It serves as a source of hormones and as an immunological barrier. The importance of EVs in the communication of placental cells with maternal tissues has been documented in the later stages of pregnancy in humans. In exosomes (CD63-positive) produced by the placenta, several bioactive molecules (RNA, DNA, proteins, and peptides) have been detected, and their release from chorionic villous trophoblasts into maternal circulation has been confirmed [205]. The importance of placental exosomes as a communication tool contributing to placentation and development of maternal-fetal vascular exchange has been suggested. In addition, the possibility of utilizing the exosome profile in the diagnosis of placental dysfunction was proposed by Salomon et al. [206]. An increased number of CD63-positive placental exosomes in maternal plasma during the first trimester of normal pregnancy was reported by Sarker et al. [207], and their pathophysiological relevance in preeclampsia (PE) was suggested by Redman et al. [208] and Baig et al. [209]. Pillay et al. [210] considered exosomes (CD63-positive) as a useful tool for prognosis/diagnosis of PE, even allowing clinicians to distinguish two subtypes of preeclampsia (early onset and late-onset PE), and thus, helpful in clinical decisions about the timing of childbirth in PE. In addition, Salomon et al. [211] documented the relationship between placental EVs and gestational diabetes mellitus (GDM) and suggested that the differential release of exosomes from the placenta and other maternal tissues compared to healthy patients affects the endothelial cell response (cytokine release), and thus, the pro-inflammatory state of GDM. CD63-positive exosomes secreted by human placenta carrying immunomodulators that modify the maternal immune system have also been reported [212]. Furthermore, Zhang et al. [213] suggested that EVs (with CD9, CD81, and CD63 markers) can also be used for early diagnoses of fetal genetic diseases, such as fetal trisomies, chromosomal abnormalities, and de novo mutations in fetuses, thanks to the similarity of the fetal DNA in EVs from maternal plasma and cell-free DNA in maternal blood.
Burkova et al. [214] identified 11 major proteins (including tetraspanin CD81) and 27 different peptides and small proteins (molecular size 2–10 kDa) in human placental exosomes. The authors hypothesized the importance of exosome peptides for protective pathways in the mother and in the development of embryos and newborns.

5.2. Male Reproductive Tract

5.2.1. Epididymal EVs-Epididymosomes

Testicular spermatozoa, although fully differentiated, are unable to fertilize. They are released to the epididymis, which is a highly ordered and segmented tubular organ of the male genital tract divided into three regions with distinctive functions: caput, corpus, and cauda [215]. The heterogeneous cell types lining its lumen, the distribution, structure, and function of which differ along the length of the duct, ensure the processes contributing to the main role of the epididymis, which is physiological maturation of the spermatozoa, leading to motility and the ability to fertilize the oocyte (reviewed in Reference [216]). While early and late sperm maturational events occur in the caput and corpus, the cauda region primarily serves as a reservoir for functionally mature spermatozoa. Each of these segments possesses distinctive gene expression profiles within the epithelium, which results in the segment-specific secretion of proteins into the luminal fluid that directly or indirectly affect sperm maturation (reviewed in Reference [217]). Sperm epididymal maturation is associated with morphological, biochemical, and physiological changes, such as the incorporating new molecules derived from the epididymal epithelium and post-translational modifications of endogenous proteins synthesized during spermiogenesis in the testis. These processes result in a sperm progressive movement, migration of the cytoplasmic droplet, changes in the sperm proteome, and changes in the sperm surface (reviewed in Reference [218]), including an increase in total negative surface charge, modifications to lectin-binding properties, changes in membrane lipid composition, remodeling of raft membrane microdomains and of other plasma membrane structures, modifications of surface glycoproteins, and surface antigen relocalization (reviewed in Reference [219]). The mutual communication of different epididymal epithelial cell types (principal, narrow, clear, and basal cells) generates a luminal microenvironment appropriate for sperm maturation and storage in the epididymis. An important role within these processes is attributed to EVs called epididymosomes, which are released by principal cells into the lumen of the epididymal duct (reviewed in Reference [218]). Epididymosomes have been observed in the epididymal fluid of hamsters [220], rats [221], sheep [222], mice [223], monkeys [224], cattle [225], and humans [224]. Epididymosomes are defined as small membranous vesicles (25–300 nm in diameter) that contain different proteins, lipids, and non-coding RNAs (reviewed in Reference [218]). Animal and human studies have provided much evidence for the contribution of EVs to sperm maturation. However, to date, there is limited evidence for the roles of specific types of EVs (reviewed in Reference [36]).
Epididymosomes collected from different segments of the epididymis are highly heterogeneous in size and content, which may explain differences in protein transfer. Epididymosomal proteins can either be incorporated into the sperm plasma membrane or into intracellular structures (reviewed in Reference [218]). It was reported that compartmentalization of proteins in epididymosomes is critical for the coordination of protein transfer to specific sperm compartments or structures [226]. Nevertheless, the exact mechanism by which epididymosomes transfer proteins to sperm remains elusive [227]. Knowing that tetraspanin proteins ensure compartmentalization of proteins in membranes of other somatic cells, it is likely that they participate in epididymal sperm maturation, at least in this manner. Thimon et al. [228] analyzed the protein composition of human epididymosomes isolated from epididymal fluid collected during the vasovasostomy procedure and identified 146 proteins, including the tetraspanins CD9, CD81, CD63, and tetraspanin-1. Moreover, the protein composition of epididymosomes differed from that of prostasomes. Recently, a study by Nixon et al. [229] presented a comparative proteomic analysis of epididymosomes isolated from different segments of the mouse epididymis, and a total of 1640 proteins, including the tetraspanins CD9, CD63, CD81, CD82, CD151, tetraspanin-6, tetraspanin-8, tetraspanin-9, and tetraspanin-14, were identified and quantified. They also demonstrated the uptake of protein cargo of mouse epididymosomes, primarily into the head of caput sperm.
Based on the presence of the tetraspanin CD9, two distinct populations of epididymosomes were characterized in the bovine epididymal fluid. The CD9-positive population of vesicles fused with spermatozoa in complex with P25b and GliPriL1 (Glioma pathogenesis-related 1-like protein 1), both known to be involved in the sperm-egg interaction, and with MIF (Macrophage migration inhibitory factor) and AKR1B1 (Aldo-keto reductase family 1 member B1), proteins involved in sperm motility. These vesicles preferentially bound to or fused with live sperm, in contrast to the other vesicle population, which was enriched in ELSPBP1 (epididymal sperm binding protein 1) and had a high affinity for dead spermatozoa. Although both EV populations bound to the same sperm regions (acrosome and midpiece) with the same kinetics [230], CD9-positive vesicles fused with sperm via a tetraspanin complex and transferred proteins important for sperm maturation, while the other vesicles likely protected live spermatozoa against ROS generated by dying spermatozoa through the scavenger activity of BLVRA (Biliverdin Reductase A), a partner of ELSPBP1 [231]. Some epididymal proteins are anchored to spermatozoa by glycosylphosphatidylinositol (GPI) residues [232]. Typically, a GPI anchor is attached to the nascent protein in the endoplasmic reticulum [233], but there is experimental evidence that some newly acquired proteins are GPI anchored to spermatozoa during epididymal transit. One of them is P25b in cattle [225] or P26h in hamsters, which has been mentioned previously [234]. Another one is a CD52-like molecule (bovine maturation-associated sperm membrane antigen), detected by Michalková et al. [235]. Based on the assumption of Lefèvre et al. [236], who suggested an association between tetraspanins and GPI proteins, and the findings of de Gassart et al. [237], who reported clustering of GPI-anchored proteins and membrane-associated ligands into microdomains on the surface of EVs (exosomes), one could expect tetraspanin ‘assistance’ in the transport of GPI proteins on the epididymal sperm membrane via EVs.

5.2.2. EVs in Semen

Mammalian semen (seminal fluid) released during ejaculation consists of spermatozoa and seminal plasma, the mix secreted by the epididymis, rete testis, and accessory sex organs/glands (prostate gland, seminal vesicles, and bulbourethral glands also known as Cowper’s glands). The composition of seminal fluid differs not only among species, but also between males of one species and even between ejaculates of the same male. Currently, it is clear that in addition to the major components, such as peptides, proteins, enzymes, hormones, cytokines, lipids, sugars, and ions (reviewed in Reference [238]), EVs interacting with spermatozoa are undoubtedly also a part of seminal plasma (reviewed in Reference [239]). While Rolland et al. [240] reported that human seminal plasma contains 2545 unique proteins, Yang et al. [239] identified only a total of 1474 proteins, of which 58.6% (864) were overlapping with the human seminal plasma exosomal proteome, and suggested that their biological role was likely related to metabolism, energy pathways, cell growth and maintenance, and transport. In human ejaculate, eleven subcategories of EVs were observed, and 59% were single vesicles, and 41% consisted of multifaceted formations [241]. Seminal plasma provides not only a suitable medium to convey sperm to the female genital tract and ensures sperm survival and function, but also regulates the female immune system (reviewed in Reference [242]). Although the exact physiologic role of EVs in seminal plasma has not yet been fully elucidated, it is believed that EVs are involved in many of these processes (reviewed in Reference [243]). EVs in seminal plasma can be distinguished by origin as epididymosomes, prostasomes, or vesicles of seminal plasma, which represents a mix of EVs with an undefined origin.

5.2.3. Prostasomes

Prostasomes were first identified in human seminal fluid as organelles in prostatic secretion [244,245], and therefore, were named ‘prostasomes’ [246]. They were described as intracellular microvesicles (50–500 nm in diameter) inside another larger vesicle, a so-called storage vesicle, equivalent to multivesicular bodies of late endosomal origin. Prostasomes are produced by the endosome-containing epithelial cells lining the acinar ducts within the tissue of the prostate gland. The fusion between the membrane surrounding the storage vesicle and the plasma membrane of the prostate acinar cell (exocytosis) enables the release of prostasomes into prostatic fluid [246,247]. Prostasomes can be involved in fertilization in several ways. They can participate in the promotion of sperm forward motility and hyperactivation through the regulation of Ca2+ homeostasis. Prostasomes can protect spermatozoa from reactive oxygen species and against the female immune system through complement inhibitory activity, they have antibacterial properties and can regulate sperm capacitation through cholesterol transfer, and they have been implicated in the acrosome reaction (reviewed in Reference [248]).
Although there are several studies on tetraspanins regarding epididymosomes, prostasomes, and other populations of EVs in seminal plasma, tetraspanins are mostly used as markers of EVs and not as an object of interest.
Aalberts et al. [249] found the tetraspanin CD9 in human prostasomes and later CD9, specifically associated with 50–150 nm vesicles [250]. Du et al. [251] observed a positive effect of CD9- and CD63-positive EVs (exosomes) isolated from boar seminal plasma on several parameters of sperm ‘quality’. Sperm showed prolonged effective motility time, improved plasma membrane integrity and antioxidant capacity, and inhibited premature capacitation. However, it should be noted that it is not known which molecules are responsible for these effects. Brzozowski et al. [252] demonstrated that alteration of CD9 and CD151 on prostate cells changed the proteome of derived EVs and that these EVs can subsequently enhance the migration and invasiveness of a non-tumorigenic population of prostate cells. The presence of exosomes (CD9-, CD81-, CD63-positive) in all fractions of boar seminal plasma was confirmed by Alvarez-Rodriguez et al. [242].
Barranco et al. [253] documented different tetraspanin expression profiles on exosomes and microvesicles of boar semen, observing that the proportion of EVs expressing CD63 and CD9 was higher in microvesicles than in exosomes, in contrast to CD81, which indicated distinct cargo, binding, and roles of EV subpopulations. These findings emphasized the need to directly focus on the role of EV tetraspanins in a broader sense rather than merely as EV markers.
Interestingly, Alvarez-Rodriguez et al. [254] were not able to detect CD9 (or CD44) in chicken seminal plasma, and they observed no or rare extracellular vesicles, suggesting that interaction of avian seminal fluid with the female genital tract occurs in a manner distinct from that in mammals.

6. Conclusions

Extensive research in the field of extracellular vesicles has shown their participation via their molecular cargo in many cellular functions in mammals. Although currently, tetraspanin proteins are applied mostly as markers of extracellular vesicles, consistent with the recommendation of the International Society for Extracellular Vesicles [255], increasing evidence points to their pivotal role in EV biogenesis, cargo selection, cell targeting, and uptake, which underlies their effect on distinct cellular processes under both physiological and pathological conditions. Notably, tetraspanins have been shown to be involved in sperm-egg interaction. Moreover, mammalian cells of both the male and female reproductive systems produce different EV populations, and their role in the processes of gamete maturation, fertilization, and embryo development has been suggested. These findings emphasize the need to consider the significance of tetraspanins regarding the message they transport. The data regarding the presence of tetraspanin-positive EVs during reproduction are summarized and illustrated in Figure 4.
Understanding the enigmatic role of EV tetraspanins is challenging, due to their complexity. Their individual abundance differs among species, individuals, organs, and anatomical regions and is dependent on sexual maturity and the presence of gametes or an embryo (e.g., oocyte, sperm, or early embryo in the oviduct; sperm or embryo in the uterus). Moreover, their study within reproductive organs is complicated by the occurrence of vesicle populations from various sources at the same time in the same place (e.g., EVs from ejaculate and EVs from the uterus after ejaculation or EVs of the uterus and embryo after fertilization). In addition, the possible differences in EV content produced by in vitro and in vivo cultivated oocytes or embryos should be taken into consideration.
Researchers working in the field of EV tetraspanins in reproductive physiology face many difficulties related to their function in multimolecular complexes. Their composition likely differs depending on the processes in which they are involved.
In sum, the constantly updated knowledge regarding extracellular vesicles has provided substantial findings that markedly change the point of view on physiological, as well as pathological processes, and the contribution of EV tetraspanins should not be omitted.

Author Contributions

J.J., P.S., K.M. and J.A. prepared the manuscript draft. J.J. and P.S prepared the figures. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences (VEGA-2/0027/20), by the Slovak Research and Development Agency (APVV-15-0196 and APVV-19-0111).

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

ABsApoptotic bodies
AKR1B1Aldo-keto reductase family 1 member B1
ALIXALG-2 interacting protein X (programmed cell death 6 interacting protein)
APCsAntigen-presenting cells
BLVRABiliverdin reductase A
CCsCumulus cells
CDCluster of differentiation
COCCumulus-oocyte complex
eEVsEmbryonal extracellular vesicles
ELSPBP1Epididymal sperm binding protein 1
ESCRTEndosomal sorting complex required for transport
EVsExtracellular vesicles
EWIProteins, members of immunoglobulin superfamily
EXsExosomes
FFFollicular fluid
GDMGestational diabetes mellitus
GliPriL1Glioma pathogenesis-related 1-like protein 1
GPIGlycosylphosphatidylinositol
HSPHeat shock proteins
ICAMIntracellular adhesion molecule
LELLarge extracellular loop
MHCMajor histocompatibility complex
MIFMacrophage migration inhibitory factor
MIIMetaphase II
MVsMicrovesicles
oEVsOviductal extracellular vesicles
PEPreeclampsia
PMCA4Plasma membrane calcium ATPase 4
PVSPerivitelline space
RABProteins included in regulation of endocytosis and secretory processes
ROSReactive oxygen species
SELSmall extracellular loop
SPAMSperm adhesion molecule
SSTsSperm storage tubules
TEMsTetraspanin-enriched microdomains
TSG101Tumor susceptibility gene 101 protein
TZPsTranszonal projections
VDAC1/2Voltage-dependent anion-selective channel protein 1/2
ZPZona pellucida

References

  1. Keller, S.; Ridinger, J.; Rupp, A.-K.; Janssen, J.W.; Altevogt, P. Body fluid derived exosomes as a novel template for clinical diagnostics. J. Transl. Med. 2011, 9, 86. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Silverman, J.M.; Clos, J.; de’Oliveira, C.C.; Shirvani, O.; Fang, Y.; Wang, C.; Foster, L.J.; Reiner, N.E. An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J. Cell. Sci. 2010, 123, 842–852. [Google Scholar] [CrossRef] [Green Version]
  3. Klibi, J.; Niki, T.; Riedel, A.; Pioche-Durieu, C.; Souquere, S.; Rubinstein, E.; Le Moulec, S.; Moulec, S.L.E.; Guigay, J.; Hirashima, M.; et al. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 2009, 113, 1957–1966. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Mathivanan, S.; Ji, H.; Simpson, R.J. Exosomes: Extracellular organelles important in intercellular communication. J. Proteom. 2010, 73, 1907–1920. [Google Scholar] [CrossRef] [PubMed]
  5. Simpson, R.J.; Lim, J.W.; Moritz, R.L.; Mathivanan, S. Exosomes: Proteomic insights and diagnostic potential. Expert Rev. Proteom. 2009, 6, 267–283. [Google Scholar] [CrossRef] [PubMed]
  6. Lässer, C.; Alikhani, V.S.; Ekström, K.; Eldh, M.; Paredes, P.T.; Bossios, A.; Sjöstrand, M.; Gabrielsson, S.; Lötvall, J.; Valadi, H. Human saliva, plasma and breast milk exosomes contain RNA: Uptake by macrophages. J. Transl. Med. 2011, 9, 9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Admyre, C.; Johansson, S.M.; Qazi, K.R.; Filén, J.-J.; Lahesmaa, R.; Norman, M.; Neve, E.P.A.; Scheynius, A.; Gabrielsson, S. Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 2007, 179, 1969–1978. [Google Scholar] [CrossRef]
  8. Montoro-García, S.; Shantsila, E.; Marín, F.; Blann, A.; Lip, G.Y.H. Circulating microparticles: New insights into the biochemical basis of microparticle release and activity. Basic Res. Cardiol. 2011, 106, 911–923. [Google Scholar] [CrossRef]
  9. Keerthikumar, S.; Chisanga, D.; Ariyaratne, D.; Al Saffar, H.; Anand, S.; Zhao, K.; Samuel, M.; Pathan, M.; Jois, M.; Chilamkurti, N.; et al. ExoCarta: A Web-Based Compendium of Exosomal Cargo. J. Mol. Biol. 2016, 428, 688–692. [Google Scholar] [CrossRef] [Green Version]
  10. Mathivanan, S.; Fahner, C.J.; Reid, G.E.; Simpson, R.J. ExoCarta 2012: Database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 2012, 40, 1241–1244. [Google Scholar] [CrossRef] [Green Version]
  11. Mathivanan, S.; Simpson, R.J. ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 2009, 9, 4997–5000. [Google Scholar] [CrossRef] [PubMed]
  12. Pathan, M.; Fonseka, P.; Chitti, S.V.; Kang, T.; Sanwlani, R.; Van Deun, J.; Hendrix, A.; Mathivanan, S. Vesiclepedia 2019: A compendium of RNA, proteins, lipids and metabolites in extracellular vesicles. Nucleic Acids Res. 2019, 47, D516–D519. [Google Scholar] [CrossRef] [Green Version]
  13. Kalra, H.; Simpson, R.J.; Ji, H.; Aikawa, E.; Altevogt, P.; Askenase, P.; Bond, V.C.; Borràs, F.E.; Breakefield, X.; Budnik, V.; et al. Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation. PLoS Biol. 2012, 10, e1001450. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Wolf, P. The nature and significance of platelet products in human plasma. Br. J. Haematol. 1967, 13, 269–288. [Google Scholar] [CrossRef] [PubMed]
  15. Barrachina, M.N.; Calderón-Cruz, B.; Fernandez-Rocca, L.; García, Á. Application of Extracellular Vesicles Proteomics to Cardiovascular Disease: Guidelines, Data Analysis, and Future Perspectives. Proteomics 2019, 19, 1800247. [Google Scholar] [CrossRef] [Green Version]
  16. György, B.; Szabó, T.G.; Pásztói, M.; Pál, Z.; Misják, P.; Aradi, B.; László, V.; Pállinger, É.; Pap, E.; Kittel, Á.; et al. Membrane vesicles, current state-of-the-art: Emerging role of extracellular vesicles. Cell. Mol. Life Sci. 2011, 68, 2667–2688. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Kerr, J.F.R.; Wyllie, A.H.; Currie, A.R. Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics. Br. J. Cancer 1972, 26, 239–257. [Google Scholar] [CrossRef] [Green Version]
  18. Théry, C.; Ostrowski, M.; Segura, E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009, 9, 581–593. [Google Scholar] [CrossRef]
  19. Shah, R.; Patel, T.; Freedman, J.E. Circulating Extracellular Vesicles in Human Disease. N. Engl. J. Med. 2018, 379, 958–966. [Google Scholar] [CrossRef]
  20. Février, B.; Raposo, G. Exosomes: Endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 2004, 16, 415–421. [Google Scholar] [CrossRef]
  21. Raposo, G.; Nijman, H.W.; Stoorvogel, W.; Liejendekker, R.; Harding, C.V.; Melief, C.J.; Geuze, H.J. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 1996, 183, 1161–1172. [Google Scholar] [CrossRef] [PubMed]
  22. van der Pol, E.; Böing, A.N.; Harrison, P.; Sturk, A.; Nieuwland, R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 2012, 64, 676–705. [Google Scholar] [CrossRef] [Green Version]
  23. Hood, J.L.; San, R.S.; Wickline, S.A. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 2011, 71, 3792–3801. [Google Scholar] [CrossRef] [Green Version]
  24. Peinado, H.; Alečković, M.; Lavotshkin, S.; Matei, I.; Costa-Silva, B.; Moreno-Bueno, G.; Hergueta-Redondo, M.; Williams, C.; García-Santos, G.; Nitadori-Hoshino, A.; et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 2012, 18, 883–891. [Google Scholar] [CrossRef] [Green Version]
  25. Mittelbrunn, M.; Gutiérrez-Vázquez, C.; Villarroya-Beltri, C.; González, S.; Sánchez-Cabo, F.; González, M.Á.; Bernad, A.; Sánchez-Madrid, F. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2011, 2, 282. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Willms, E.; Cabañas, C.; Mäger, I.; Wood, M.J.A.; Vader, P. Extracellular Vesicle Heterogeneity: Subpopulations, Isolation Techniques, and Diverse Functions in Cancer Progression. Front. Immunol. 2018, 9, 738. [Google Scholar] [CrossRef] [Green Version]
  27. van Niel, G.; D’Angelo, G.; Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 2018, 19, 213–228. [Google Scholar] [CrossRef]
  28. van Niel, G.; Porto-Carreiro, I.; Simoes, S.; Raposo, G. Exosomes: A common pathway for a specialized function. J. Biochem. 2006, 140, 13–21. [Google Scholar] [CrossRef] [PubMed]
  29. Raposo, G.; Stoorvogel, W. Extracellular vesicles: Exosomes, microvesicles, and friends. J. Cell Biol. 2013, 200, 373–383. [Google Scholar] [CrossRef] [Green Version]
  30. Subra, C.; Laulagnier, K.; Perret, B.; Record, M. Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie 2007, 89, 205–212. [Google Scholar] [CrossRef]
  31. Laulagnier, K.; Motta, C.; Hamdi, S.; Roy, S.; Fauvelle, F.; Pageaux, J.-F.; Kobayashi, T.; Salles, J.-P.; Perret, B.; Bonnerot, C.; et al. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem. J. 2004, 380, 161–171. [Google Scholar] [CrossRef] [PubMed]
  32. Skotland, T.; Sandvig, K.; Llorente, A. Lipids in exosomes: Current knowledge and the way forward. Prog. Lipid Res. 2017, 66, 30–41. [Google Scholar] [CrossRef]
  33. Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J.J.; Lötvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654–659. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Cufaro, M.C.; Pieragostino, D.; Lanuti, P.; Rossi, C.; Cicalini, I.; Federici, L.; De Laurenzi, V.; Del Boccio, P. Extracellular Vesicles and Their Potential Use in Monitoring Cancer Progression and Therapy: The Contribution of Proteomics. J. Oncol. 2019, 2019, 1–19. [Google Scholar] [CrossRef]
  35. Ahmed, K.A.; Xiang, J. Mechanisms of cellular communication through intercellular protein transfer. J. Cell Mol. Med. 2011, 15, 1458–1473. [Google Scholar] [CrossRef] [PubMed]
  36. Machtinger, R.; Laurent, L.C.; Baccarelli, A.A. Extracellular vesicles: Roles in gamete maturation, fertilization and embryo implantation. Hum. Reprod. Update 2016, 22, 182–193. [Google Scholar] [CrossRef] [PubMed]
  37. Zöller, M. Tetraspanins: Push and pull in suppressing and promoting metastasis. Nat. Rev. Cancer 2009, 9, 40–55. [Google Scholar] [CrossRef] [PubMed]
  38. Rana, S.; Zöller, M. Exosome target cell selection and the importance of exosomal tetraspanins: A hypothesis. Biochem. Soc. Trans. 2011, 39, 559–562. [Google Scholar] [CrossRef] [Green Version]
  39. Rana, S.; Yue, S.; Stadel, D.; Zöller, M. Toward tailored exosomes: The exosomal tetraspanin web contributes to target cell selection. Int. J. Biochem. Cell Biol. 2012, 44, 1574–1584. [Google Scholar] [CrossRef]
  40. Kaji, K.; Oda, S.; Shikano, T.; Ohnuki, T.; Uematsu, Y.; Sakagami, J.; Tada, N.; Miyazaki, S.; Kudo, A. The gamete fusion process is defective in eggs of Cd9-deficient mice. Nat. Genet. 2000, 24, 279–282. [Google Scholar] [CrossRef]
  41. Le Naour, F.; Rubinstein, E.; Jasmin, C.; Prenant, M.; Boucheix, C. Severely reduced female fertility in CD9-deficient mice. Science 2000, 287, 319–321. [Google Scholar] [CrossRef]
  42. Miyado, K. Requirement of CD9 on the Egg Plasma Membrane for Fertilization. Science 2000, 287, 321–324. [Google Scholar] [CrossRef] [PubMed]
  43. Stipp, C.S.; Kolesnikova, T.V.; Hemler, M.E. Functional domains in tetraspanin proteins. Trends Biochem. Sci. 2003, 28, 106–112. [Google Scholar] [CrossRef]
  44. Berditchevski, F.; Odintsova, E.; Sawada, S.; Gilbert, E. Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling. J. Biol. Chem. 2002, 277, 36991–37000. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Charrin, S.; Manié, S.; Oualid, M.; Billard, M.; Boucheix, C.; Rubinstein, E. Differential stability of tetraspanin/tetraspanin interactions: Role of palmitoylation. FEBS Lett. 2002, 516, 139–144. [Google Scholar] [CrossRef] [Green Version]
  46. Yang, X.; Claas, C.; Kraeft, S.-K.; Chen, L.B.; Wang, Z.; Kreidberg, J.A.; Hemler, M.E. Palmitoylation of Tetraspanin Proteins: Modulation of CD151 Lateral Interactions, Subcellular Distribution, and Integrin-dependent Cell Morphology. Mol. Biol Cell 2002, 13, 767–781. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Huang, S.; Yuan, S.; Dong, M.; Su, J.; Yu, C.; Shen, Y.; Xie, X.; Yu, Y.; Yu, X.; Chen, S.; et al. The phylogenetic analysis of tetraspanins projects the evolution of cell–cell interactions from unicellular to multicellular organisms. Genomics 2005, 86, 674–684. [Google Scholar] [CrossRef] [Green Version]
  48. Boucheix, C.; Rubinstein, E. Tetraspanins. Cell. Mol. Life Sci. 2001, 58, 1189–1205. [Google Scholar] [CrossRef]
  49. Tang, M.; Yin, G.; Wang, F.; Liu, H.; Zhou, S.; Ni, J.; Chen, C.; Zhou, Y.; Zhao, Y. Downregulation of CD9 promotes pancreatic cancer growth and metastasis through upregulation of epidermal growth factor on the cell surface. Oncol. Rep. 2015, 34, 350–358. [Google Scholar] [CrossRef]
  50. Berditchevski, F.; Odintsova, E. Tetraspanins as regulators of protein trafficking. Traffic 2007, 8, 89–96. [Google Scholar] [CrossRef]
  51. Hemler, M.E. Specific tetraspanin functions. J. Cell Biol. 2001, 155, 1103–1108. [Google Scholar] [CrossRef] [PubMed]
  52. Hemler, M.E. Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell Biol. 2005, 6, 801–811. [Google Scholar] [CrossRef] [PubMed]
  53. Charrin, S.; le Naour, F.; Silvie, O.; Milhiet, P.-E.; Boucheix, C.; Rubinstein, E. Lateral organization of membrane proteins: Tetraspanins spin their web. Biochem. J. 2009, 420, 133–154. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Hemler, M.E. Integrin associated proteins. Curr. Opin. Cell Biol. 1998, 10, 578–585. [Google Scholar] [CrossRef]
  55. Winterwood, N.E.; Varzavand, A.; Meland, M.N.; Ashman, L.K.; Stipp, C.S. A Critical Role for Tetraspanin CD151 in α3β1 and α6β4 Integrin–dependent Tumor Cell Functions on Laminin-5. Mol. Biol Cell 2006, 17, 2707–2721. [Google Scholar] [CrossRef] [Green Version]
  56. Boucheix, C.; Duc, G.H.; Jasmin, C.; Rubinstein, E. Tetraspanins and malignancy. Expert Rev. Mol. Med. 2001, 3. [Google Scholar] [CrossRef]
  57. Berditchevski, F. Complexes of tetraspanins with integrins: More than meets the eye. J. Cell Sci. 2001, 114, 4143–4151. [Google Scholar]
  58. Yáñez-Mó, M.; Mittelbrunn, M.; Sánchez-Madrid, F. Tetraspanins and Intercellular Interactions. Microcirculation 2001, 8, 153–168. [Google Scholar] [CrossRef]
  59. Hemler, M.E. Targeting of tetraspanin proteins—Potential benefits and strategies. Nat. Rev. Drug Discov. 2008, 7, 747–758. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. van Spriel, A.B.; Figdor, C.G. The role of tetraspanins in the pathogenesis of infectious diseases. Microbes Infect. 2010, 12, 106–112. [Google Scholar] [CrossRef]
  61. Martin, F.; Roth, D.M.; Jans, D.A.; Pouton, C.W.; Partridge, L.J.; Monk, P.N.; Moseley, G.W. Tetraspanins in Viral Infections: A Fundamental Role in Viral Biology? J. Virol. 2005, 79, 10839–10851. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Florin, L.; Lang, T. Tetraspanin Assemblies in Virus Infection. Front. Immunol. 2018, 9, 1140. [Google Scholar] [CrossRef] [PubMed]
  63. Hemler, M.E. Tetraspanin proteins promote multiple cancer stages. Nat. Rev. Cancer 2014, 14, 49–60. [Google Scholar] [CrossRef] [PubMed]
  64. Detchokul, S.; Williams, E.D.; Parker, M.W.; Frauman, A.G. Tetraspanins as regulators of the tumour microenvironment: Implications for metastasis and therapeutic strategies. Br. J. Pharmacol. 2014, 171, 5462–5490. [Google Scholar] [CrossRef] [Green Version]
  65. Escola, J.M.; Kleijmeer, M.J.; Stoorvogel, W.; Griffith, J.M.; Yoshie, O.; Geuze, H.J. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 1998, 273, 20121–20127. [Google Scholar] [CrossRef] [Green Version]
  66. Simpson, R.J.; Kalra, H.; Mathivanan, S. ExoCarta as a resource for exosomal research. J. Extracell. Vesicles 2012, 1, 18374. [Google Scholar] [CrossRef]
  67. Kim, M.; Park, H.J.; Seol, J.W.; Jang, J.Y.; Cho, Y.; Kim, K.R.; Choi, Y.; Lydon, J.P.; DeMayo, F.J.; Shibuya, M.; et al. VEGF—A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancy. EMBO Mol. Med. 2013, 5, 1415–1430. [Google Scholar] [CrossRef]
  68. Lozano-Andrés, E.; Libregts, S.F.; Toribio, V.; Royo, F.; Morales, S.; López-Martín, S.; Valés-Gómez, M.; Reyburn, H.T.; Falcón-Pérez, J.M.; Wauben, M.H.; et al. Tetraspanin-decorated extracellular vesicle-mimetics as a novel adaptable reference material. J. Extracell. Vesicles 2019, 8, 1573052. [Google Scholar] [CrossRef] [Green Version]
  69. Stuffers, S.; Sem Wegner, C.; Stenmark, H.; Brech, A. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic 2009, 10, 925–937. [Google Scholar] [CrossRef]
  70. Trajkovic, K.; Hsu, C.; Chiantia, S.; Rajendran, L.; Wenzel, D.; Wieland, F.; Schwille, P.; Brügger, B.; Simons, M. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008, 319, 1244–1247. [Google Scholar] [CrossRef]
  71. van Niel, G.; Charrin, S.; Simoes, S.; Romao, M.; Rochin, L.; Saftig, P.; Marks, M.S.; Rubinstein, E.; Raposo, G. The Tetraspanin CD63 Regulates ESCRT-Independent and -Dependent Endosomal Sorting during Melanogenesis. Dev. Cell 2011, 21, 708–721. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Chairoungdua, A.; Smith, D.L.; Pochard, P.; Hull, M.; Caplan, M.J. Exosome release of β-catenin: A novel mechanism that antagonizes Wnt signaling. J. Cell. Biol. 2010, 190, 1079–1091. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Bari, R.; Guo, Q.; Xia, B.; Zhang, Y.H.; Giesert, E.E.; Levy, S.; Zheng, J.J.; Zhang, X.A. Tetraspanins regulate the protrusive activities of cell membrane. Biochem. Biophys. Res. Commun. 2011, 415, 619–626. [Google Scholar] [CrossRef] [Green Version]
  74. Umeda, R.; Satouh, Y.; Takemoto, M.; Nakada-Nakura, Y.; Liu, K.; Yokoyama, T.; Shirouzu, M.; Iwata, S.; Nomura, N.; Sato, K.; et al. Structural insights into tetraspanin CD9 function. Nat. Commun. 2020, 11, 1606. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Frolikova, M.; Manaskova-Postlerova, P.; Cerny, J.; Jankovicova, J.; Simonik, O.; Pohlova, A.; Secova, P.; Antalikova, J.; Dvorakova-Hortova, K. CD9 and CD81 Interactions and Their Structural Modelling in Sperm Prior to Fertilization. Int. J. Mol. Sci. 2018, 19, 1236. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Jankovicova, J.; Frolikova, M.; Palenikova, V.; Valaskova, E.; Cerny, J.; Secova, P.; Bartokova, M.; Horovska, L.; Manaskova-Postlerova, P.; Antalikova, J.; et al. Expression and distribution of CD151 as a partner of alpha6 integrin in male germ cells. Sci. Rep. 2020, 10, 4374. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Sala-Valdés, M.; Ursa, Á.; Charrin, S.; Rubinstein, E.; Hemler, M.E.; Sánchez-Madrid, F.; Yáñez-Mó, M. EWI-2 and EWI-F Link the Tetraspanin Web to the Actin Cytoskeleton through Their Direct Association with Ezrin-Radixin-Moesin Proteins. J. Biol. Chem. 2006, 281, 19665–19675. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  78. Rana, S.; Claas, C.; Kretz, C.C.; Nazarenko, I.; Zoeller, M. Activation-induced internalization differs for the tetraspanins CD9 and Tspan8: Impact on tumor cell motility. Int. J. Biochem. Cell Biol. 2011, 43, 106–119. [Google Scholar] [CrossRef]
  79. Andreu, Z.; Yáñez-Mó, M. Tetraspanins in Extracellular Vesicle Formation and Function. Front. Immunol. 2014, 5. [Google Scholar] [CrossRef] [Green Version]
  80. Perez-Hernandez, D.; Gutiérrez-Vázquez, C.; Jorge, I.; López-Martín, S.; Ursa, A.; Sánchez-Madrid, F.; Vázquez, J.; Yáñez-Mó, M. The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J. Biol. Chem. 2013, 288, 11649–11661. [Google Scholar] [CrossRef] [Green Version]
  81. Yáñez-Mó, M.; Barreiro, O.; Gordon-Alonso, M.; Sala-Valdés, M.; Sánchez-Madrid, F. Tetraspanin-enriched microdomains: A functional unit in cell plasma membranes. Trends Cell Biol. 2009, 19, 434–446. [Google Scholar] [CrossRef] [PubMed]
  82. Bassani, S.; Cingolani, L.A. Tetraspanins: Interactions and interplay with integrins. Int. J. Biochem. Cell Biol. 2012, 44, 703–708. [Google Scholar] [CrossRef] [PubMed]
  83. Fanaei, M.; Monk, P.N.; Partridge, L.J. The role of tetraspanins in fusion. Biochem. Soc. Trans. 2011, 39, 524–528. [Google Scholar] [CrossRef] [Green Version]
  84. Kolesnikova, T.V.; Kazarov, A.R.; Lemieux, M.E.; Lafleur, M.A.; Kesari, S.; Kung, A.L.; Hemler, M.E. Glioblastoma Inhibition by Cell Surface Immunoglobulin Protein EWI-2, In Vitro and In Vivo. Neoplasia 2009, 11, 77–86. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Zhang, J.; Li, S.; Li, L.; Li, M.; Guo, C.; Yao, J.; Mi, S. Exosome and exosomal microRNA: Trafficking, sorting, and function. Genom. Proteom. Bioinform. 2015, 13, 17–24. [Google Scholar] [CrossRef] [Green Version]
  86. Minciacchi, V.R.; Freeman, M.R.; Di Vizio, D. Extracellular vesicles in cancer: Exosomes, microvesicles and the emerging role of large oncosomes. Semin. Cell Dev. Biol. 2015, 40, 41–51. [Google Scholar] [CrossRef] [Green Version]
  87. Mulcahy, L.A.; Pink, R.C.; Carter, D.R.F. Routes and mechanisms of extracellular vesicle uptake. J. Extracell. Vesicles 2014, 3, 24641. [Google Scholar] [CrossRef] [Green Version]
  88. Tian, T.; Zhu, Y.-L.; Hu, F.-H.; Wang, Y.-Y.; Huang, N.-P.; Xiao, Z.-D. Dynamics of exosome internalization and trafficking. J. Cell. Physiol. 2013, 228, 1487–1495. [Google Scholar] [CrossRef]
  89. Levy, S.; Shoham, T. The tetraspanin web modulates immune-signalling complexes. Nat. Rev. Immunol. 2005, 5, 136–148. [Google Scholar] [CrossRef]
  90. Lakkaraju, A.; Rodriguez-Boulan, E. Itinerant exosomes: Emerging roles in cell and tissue polarity. Trends Cell Biol. 2008, 18, 199–209. [Google Scholar] [CrossRef] [Green Version]
  91. Johnstone, R.M. Exosomes biological significance: A concise review. Blood Cells Mol. Dis. 2006, 36, 315–321. [Google Scholar] [CrossRef] [PubMed]
  92. Lebreton, A.; Séraphin, B. Exosome-mediated quality control: Substrate recruitment and molecular activity. Biochim. Biophys. Acta 2008, 1779, 558–565. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Schorey, J.S.; Bhatnagar, S. Exosome function: From tumor immunology to pathogen biology. Traffic 2008, 9, 871–881. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Nazarenko, I.; Rana, S.; Baumann, A.; McAlear, J.; Hellwig, A.; Trendelenburg, M.; Lochnit, G.; Preissner, K.T.; Zöller, M. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res. 2010, 70, 1668–1678. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Morelli, A.E.; Larregina, A.T.; Shufesky, W.J.; Sullivan, M.L.G.; Stolz, D.B.; Papworth, G.D.; Zahorchak, A.F.; Logar, A.J.; Wang, Z.; Watkins, S.C.; et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 2004, 104, 3257–3266. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Zech, D.; Rana, S.; Büchler, M.W.; Zöller, M. Tumor-exosomes and leukocyte activation: An ambivalent crosstalk. Cell Commun. Signal. 2012, 10, 37. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  97. Stoeck, A.; Keller, S.; Riedle, S.; Sanderson, M.P.; Runz, S.; Le Naour, F.; Gutwein, P.; Ludwig, A.; Rubinstein, E.; Altevogt, P. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem. J. 2006, 393, 609–618. [Google Scholar] [CrossRef]
  98. Hawari, F.I.; Rouhani, F.N.; Cui, X.; Yu, Z.-X.; Buckley, C.; Kaler, M.; Levine, S.J. Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: A mechanism for generation of soluble cytokine receptors. Proc. Natl. Acad. Sci. USA 2004, 101, 1297–1302. [Google Scholar] [CrossRef] [Green Version]
  99. Hakulinen, J.; Junnikkala, S.; Sorsa, T.; Meri, S. Complement inhibitor membrane cofactor protein (MCP.; CD46) is constitutively shed from cancer cell membranes in vesicles and converted by a metalloproteinase to a functionally active soluble form. Eur. J. Immunol. 2004, 34, 2620–2629. [Google Scholar] [CrossRef]
  100. Christianson, H.C.; Svensson, K.J.; van Kuppevelt, T.H.; Li, J.-P.; Belting, M. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc. Natl. Acad. Sci. USA 2013, 110, 17380–17385. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  101. Menck, K.; Klemm, F.; Gross, J.C.; Pukrop, T.; Wenzel, D.; Binder, C. Induction and transport of Wnt 5a during macrophage-induced malignant invasion is mediated by two types of extracellular vesicles. Oncotarget 2013, 4, 2057–2066. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  102. Atay, S.; Gercel-Taylor, C.; Taylor, D.D. Human trophoblast-derived exosomal fibronectin induces pro-inflammatory IL-1β production by macrophages. Am. J. Reprod. Immunol. 2011, 66, 259–269. [Google Scholar] [CrossRef] [PubMed]
  103. Otto, G.P.; Nichols, B.J. The roles of flotillin microdomains--endocytosis and beyond. J. Cell. Sci. 2011, 124, 3933–3940. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Volonte, D.; Galbiati, F.; Li, S.; Nishiyama, K.; Okamoto, T.; Lisanti, M.P. Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe. J. Biol. Chem. 1999, 274, 12702–12709. [Google Scholar] [CrossRef] [Green Version]
  105. Bickel, P.E.; Scherer, P.E.; Schnitzer, J.E.; Oh, P.; Lisanti, M.P.; Lodish, H.F. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J. Biol. Chem. 1997, 272, 13793–13802. [Google Scholar] [CrossRef] [Green Version]
  106. Frick, M.; Bright, N.A.; Riento, K.; Bray, A.; Merrified, C.; Nichols, B.J. Coassembly of flotillins induces formation of membrane microdomains, membrane curvature, and vesicle budding. Curr. Biol. 2007, 17, 1151–1156. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  107. Jahn, R.; Lang, T.; Südhof, T.C. Membrane fusion. Cell 2003, 112, 519–533. [Google Scholar] [CrossRef] [Green Version]
  108. Logozzi, M.; De Milito, A.; Lugini, L.; Borghi, M.; Calabrò, L.; Spada, M.; Perdicchio, M.; Marino, M.L.; Federici, C.; Iessi, E.; et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE 2009, 4, e5219. [Google Scholar] [CrossRef] [Green Version]
  109. Chernomordik, L.V.; Kozlov, M.M. Mechanics of membrane fusion. Nat. Struct. Mol. Biol. 2008, 15, 675–683. [Google Scholar] [CrossRef] [Green Version]
  110. Naito, Y.; Yoshioka, Y.; Yamamoto, Y.; Ochiya, T. How cancer cells dictate their microenvironment: Present roles of extracellular vesicles. Cell. Mol. Life Sci. 2017, 74, 697–713. [Google Scholar] [CrossRef] [Green Version]
  111. Lu, J.; Li, J.; Liu, S.; Wang, T.; Ianni, A.; Bober, E.; Braun, T.; Xiang, R.; Yue, S. Exosomal tetraspanins mediate cancer metastasis by altering host microenvironment. Oncotarget 2017, 8, 62803–62815. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  112. Whiteside, T.L. Exosomes and tumor-mediated immune suppression. J. Clin. Invest. 2016, 126, 1216–1223. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  113. Yue, S.; Mu, W.; Erb, U.; Zöller, M. The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding. Oncotarget 2014, 6, 2366–2384. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  114. Mu, W.; Rana, S.; Zöller, M. Host Matrix Modulation by Tumor Exosomes Promotes Motility and Invasiveness. Neoplasia 2013, 15, 875–887. [Google Scholar] [CrossRef] [Green Version]
  115. Yang, C.; Robbins, P.D. The Roles of Tumor-Derived Exosomes in Cancer Pathogenesis. Clin. Dev. Immunol. 2011, 2011. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  116. Hoshino, A.; Costa-Silva, B.; Shen, T.-L.; Rodrigues, G.; Hashimoto, A.; Mark, M.T.; Molina, H.; Kohsaka, S.; Di Giannatale, A.; Ceder, S.; et al. Tumour exosome integrins determine organotropic metastasis. Nature 2015, 527, 329–335. [Google Scholar] [CrossRef] [Green Version]
  117. Lindenbergh, M.F.S.; Stoorvogel, W. Antigen Presentation by Extracellular Vesicles from Professional Antigen-Presenting Cells. Annu. Rev. Immunol. 2018, 36, 435–459. [Google Scholar] [CrossRef]
  118. Szajnik, M.; Czystowska, M.; Szczepanski, M.J.; Mandapathil, M.; Whiteside, T.L. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS ONE 2010, 5, e11469. [Google Scholar] [CrossRef] [Green Version]
  119. Zitvogel, L.; Regnault, A.; Lozier, A.; Wolfers, J.; Flament, C.; Tenza, D.; Ricciardi-Castagnoli, P.; Raposo, G.; Amigorena, S. Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes. Nat. Med. 1998, 4, 594–600. [Google Scholar] [CrossRef]
  120. Mittelbrunn, M.; Yáñez-Mó, M.; Sancho, D.; Ursa, A.; Sánchez-Madrid, F. Cutting edge: Dynamic redistribution of tetraspanin CD81 at the central zone of the immune synapse in both T lymphocytes and APC. J. Immunol. 2002, 169, 6691–6695. [Google Scholar] [CrossRef] [Green Version]
  121. Rocha-Perugini, V.; Zamai, M.; Gonzalez-Granado, J.M.; Barreiro, O.; Tejera, E.; Yanez-Mo, M.; Caiolfa, V.R.; Sanchez-Madrid, F. CD81 Controls Sustained T Cell Activation Signaling and Defines the Maturation Stages of Cognate Immunological Synapses. Mol. Cell. Biol. 2013, 33, 3644–3658. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  122. Kropshofer, H.; Spindeldreher, S.; Röhn, T.A.; Platania, N.; Grygar, C.; Daniel, N.; Wölpl, A.; Langen, H.; Horejsi, V.; Vogt, A.B. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat. Immunol. 2002, 3, 61–68. [Google Scholar] [CrossRef] [PubMed]
  123. Imai, T.; Kakizaki, M.; Nishimura, M.; Yoshie, O. Molecular analyses of the association of CD4 with two members of the transmembrane 4 superfamily, CD81 and CD82. J. Immunol. 1995, 155, 1229–1239. [Google Scholar] [PubMed]
  124. Maecker, H.T.; Levy, S. Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J. Exp. Med. 1997, 185, 1505–1510. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  125. Rocha-Perugini, V.; González-Granado, J.M.; Tejera, E.; López-Martín, S.; Yañez-Mó, M.; Sanchez-Madrid, F. Tetraspanins CD9 and CD151 at the immune synapse support T-cell integrin signaling. Eur. J. Immunol. 2014, 44, 1967–1975. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  126. Unternaehrer, J.J.; Chow, A.; Pypaert, M.; Inaba, K.; Mellman, I. The tetraspanin CD9 mediates lateral association of MHC class II molecules on the dendritic cell surface. Proc. Natl. Acad. Sci. USA 2007, 104, 234–239. [Google Scholar] [CrossRef] [Green Version]
  127. Nj, P.; Lk, D.; Pa, R. CDw78 defines MHC class II-peptide complexes that require Ii chain-dependent lysosomal trafficking, not localization to a specific tetraspanin membrane microdomain. J. Immunol. 2006, 177, 5451–5458. [Google Scholar] [CrossRef] [Green Version]
  128. Wright, M.D.; Moseley, G.W.; van Spriel, A.B. Tetraspanin microdomains in immune cell signalling and malignant disease. Tissue Antigens 2004, 64, 533–542. [Google Scholar] [CrossRef]
  129. Sheng, K.-C.; van Spriel, A.B.; Gartlan, K.H.; Sofi, M.; Apostolopoulos, V.; Ashman, L.; Wright, M.D. Tetraspanins CD37 and CD151 differentially regulate Ag presentation and T-cell co-stimulation by DC. Eur. J. Immunol. 2009, 39, 50–55. [Google Scholar] [CrossRef]
  130. Matzuk, M.M. Intercellular Communication in the Mammalian Ovary: Oocytes Carry the Conversation. Science 2002, 296, 2178–2180. [Google Scholar] [CrossRef]
  131. Robker, R.L.; Hennebold, J.D.; Russell, D.L. Coordination of Ovulation and Oocyte Maturation: A Good Egg at the Right Time. Endocrinology 2018, 159, 3209–3218. [Google Scholar] [CrossRef] [PubMed]
  132. Georgiou, A.S.; Sostaric, E.; Wong, C.H.; Snijders, A.P.L.; Wright, P.C.; Moore, H.D.; Fazeli, A. Gametes Alter the Oviductal Secretory Proteome. Mol. Cell Proteom. 2005, 4, 1785–1796. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  133. Sutton, M.L. Effects of in-vivo and in-vitro environments on the metabolism of the cumulus-oocyte complex and its influence on oocyte developmental capacity. Hum. Reprod. Update 2003, 9, 35–48. [Google Scholar] [CrossRef] [PubMed]
  134. Eppig, J.J. Intercommunication between mammalian oocytes and companion somatic cells. Bioessays 1991, 13, 569–574. [Google Scholar] [CrossRef] [PubMed]
  135. Albertini, D.F.; Combelles, C.M.; Benecchi, E.; Carabatsos, M.J. Cellular basis for paracrine regulation of ovarian follicle development. Reproduction 2001, 121, 647–653. [Google Scholar] [CrossRef] [PubMed]
  136. Macaulay, A.D.; Gilbert, I.; Scantland, S.; Fournier, E.; Ashkar, F.; Bastien, A.; Saadi, H.A.S.; Gagné, D.; Sirard, M.-A.; Khandjian, É.W.; et al. Cumulus Cell Transcripts Transit to the Bovine Oocyte in Preparation for Maturation1. Biol. Reprod. 2016, 94. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  137. del Collado, M.; da Silveira, J.C.; Sangalli, J.R.; Andrade, G.M.; da Sousa, L.R.S.; Silva, L.A.; Meirelles, F.V.; Perecin, F. Fatty Acid Binding Protein 3 And Transzonal Projections Are Involved In Lipid Accumulation During In Vitro Maturation Of Bovine Oocytes. Sci. Rep. 2017, 7, 2645. [Google Scholar] [CrossRef]
  138. da Silveira, J.C.; Veeramachaneni, D.N.R.; Winger, Q.A.; Carnevale, E.M.; Bouma, G.J. Cell-Secreted Vesicles in Equine Ovarian Follicular Fluid Contain miRNAs and Proteins: A Possible New Form of Cell Communication Within the Ovarian Follicle1. Biol. Reprod. 2012, 86. [Google Scholar] [CrossRef]
  139. da Silveira, J.C.; Carnevale, E.M.; Winger, Q.A.; Bouma, G.J. Regulation of ACVR1 and ID2 by cell-secreted exosomes during follicle maturation in the mare. Reprod. Biol. Endocrinol. 2014, 12, 44. [Google Scholar] [CrossRef] [Green Version]
  140. Sohel, M.M.H.; Hoelker, M.; Noferesti, S.S.; Salilew-Wondim, D.; Tholen, E.; Looft, C.; Rings, F.; Uddin, M.J.; Spencer, T.E.; Schellander, K.; et al. Exosomal and Non-Exosomal Transport of Extra-Cellular microRNAs in Follicular Fluid: Implications for Bovine Oocyte Developmental Competence. PLoS ONE 2013, 8, e78505. [Google Scholar] [CrossRef] [Green Version]
  141. Matsuno, Y.; Kanke, T.; Maruyama, N.; Fujii, W.; Naito, K.; Sugiura, K. Characterization of mRNA profiles of the exosome-like vesicles in porcine follicular fluid. PLoS ONE 2019, 14, e0217760. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  142. da Silveira, J.C.; Andrade, G.M.; del Collado, M.; Sampaio, R.V.; Sangalli, J.R.; Silva, L.A.; Pinaffi, F.V.L.; Jardim, I.B.; Cesar, M.C.; Nogueira, M.F.G.; et al. Supplementation with small-extracellular vesicles from ovarian follicular fluid during in vitro production modulates bovine embryo development. PLoS ONE 2017, 12, e0179451. [Google Scholar] [CrossRef] [PubMed]
  143. Santonocito, M.; Vento, M.; Guglielmino, M.R.; Battaglia, R.; Wahlgren, J.; Ragusa, M.; Barbagallo, D.; Borzì, P.; Rizzari, S.; Maugeri, M.; et al. Molecular characterization of exosomes and their microRNA cargo in human follicular fluid: Bioinformatic analysis reveals that exosomal microRNAs control pathways involved in follicular maturation. Fertil. Steril. 2014, 102, 1751.e1–1761.e1. [Google Scholar] [CrossRef] [PubMed]
  144. Hu, J.; Tang, T.; Zeng, Z.; Wu, J.; Tan, X.; Yan, J. The expression of small RNAs in exosomes of follicular fluid altered in human polycystic ovarian syndrome. PeerJ 2020, 8, e8640. [Google Scholar] [CrossRef] [PubMed]
  145. Hung, W.-T.; Hong, X.; Christenson, L.K.; McGinnis, L.K. Extracellular Vesicles from Bovine Follicular Fluid Support Cumulus Expansion1. Biol. Reprod. 2015, 93. [Google Scholar] [CrossRef] [PubMed]
  146. Navakanitworakul, R.; Hung, W.-T.; Gunewardena, S.; Davis, J.S.; Chotigeat, W.; Christenson, L.K. Characterization and Small RNA Content of Extracellular Vesicles in Follicular Fluid of Developing Bovine Antral Follicles. Sci. Rep. 2016, 6, 25486. [Google Scholar] [CrossRef] [PubMed]
  147. Miyado, K.; Yoshida, K.; Yamagata, K.; Sakakibara, K.; Okabe, M.; Wang, X.; Miyamoto, K.; Akutsu, H.; Kondo, T.; Takahashi, Y.; et al. The fusing ability of sperm is bestowed by CD9-containing vesicles released from eggs in mice. Proc. Natl. Acad. Sci. USA 2008, 105, 12921–12926. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  148. Ohnami, N.; Nakamura, A.; Miyado, M.; Sato, M.; Kawano, N.; Yoshida, K.; Harada, Y.; Takezawa, Y.; Kanai, S.; Ono, C.; et al. CD81 and CD9 work independently as extracellular components upon fusion of sperm and oocyte. Biol. Open 2012, 1, 640–647. [Google Scholar] [CrossRef] [Green Version]
  149. Jankovicova, J.; Secova, P.; Manaskova-Postlerova, P.; Simonik, O.; Frolikova, M.; Chmelikova, E.; Horovska, L.; Michalkova, K.; Dvorakova-Hortova, K.; Antalikova, J. Detection of CD9 and CD81 tetraspanins in bovine and porcine oocytes and embryos. Int. J. Biol. Macromol. 2019, 123, 931–938. [Google Scholar] [CrossRef]
  150. Suarez, S.S. Chapter 5 - Gamete and Zygote Transport. In Knobil and Neill’s Physiology of Reproduction, 4th ed.; Plant, T.M., Zeleznik, A.J., Eds.; Academic Press: San Diego, CA, USA, 2015; pp. 197–232. ISBN 978-0-12-397175-3. [Google Scholar]
  151. Al-Dossary, A.A.; Strehler, E.E.; Martin-DeLeon, P.A. Expression and Secretion of Plasma Membrane Ca2+-ATPase 4a (PMCA4a) during Murine Estrus: Association with Oviductal Exosomes and Uptake in Sperm. PLoS ONE 2013, 8, e80181. [Google Scholar] [CrossRef] [Green Version]
  152. Fereshteh, Z.; Schmidt, S.A.; Al-Dossary, A.A.; Accerbi, M.; Arighi, C.; Cowart, J.; Song, J.L.; Green, P.J.; Choi, K.; Yoo, S.; et al. Murine Oviductosomes (OVS) microRNA profiling during the estrous cycle: Delivery of OVS-borne microRNAs to sperm where miR-34c-5p localizes at the centrosome. Sci. Rep. 2018, 8, 16094. [Google Scholar] [CrossRef] [PubMed]
  153. Lopera-Vásquez, R.; Hamdi, M.; Fernandez-Fuertes, B.; Maillo, V.; Beltrán-Breña, P.; Calle, A.; Redruello, A.; López-Martín, S.; Gutierrez-Adán, A.; Yañez-Mó, M.; et al. Extracellular Vesicles from BOEC in In Vitro Embryo Development and Quality. PLoS ONE 2016, 11, e0148083. [Google Scholar] [CrossRef]
  154. Almiñana, C.; Corbin, E.; Tsikis, G.; Alcântara-Neto, A.S.; Labas, V.; Reynaud, K.; Galio, L.; Uzbekov, R.; Garanina, A.S.; Druart, X.; et al. Oviduct extracellular vesicles protein content and their role during oviduct–embryo cross-talk. Reproduction 2017, 154, 253–268. [Google Scholar] [CrossRef] [PubMed]
  155. Bathala, P.; Fereshteh, Z.; Li, K.; Al-Dossary, A.A.; Galileo, D.S.; Martin-DeLeon, P.A. Oviductal extracellular vesicles (oviductosomes, OVS) are conserved in humans: Murine OVS play a pivotal role in sperm capacitation and fertility. Mol. Hum. Reprod. 2018, 24, 143–157. [Google Scholar] [CrossRef] [PubMed]
  156. Huang, A.; Isobe, N.; Yoshimura, Y. Changes in localization and density of CD63-positive exosome-like substances in the hen oviduct with artificial insemination and their effect on sperm viability. Theriogenology 2017, 101, 135–143. [Google Scholar] [CrossRef] [PubMed]
  157. Lange-Consiglio, A.; Perrini, C.; Albini, G.; Modina, S.; Lodde, V.; Orsini, E.; Esposti, P.; Cremonesi, F. Oviductal microvesicles and their effect on in vitro maturation of canine oocytes. Reproduction 2017, 154, 167–180. [Google Scholar] [CrossRef] [PubMed]
  158. Waqas, M.Y.; Zhang, Q.; Ahmed, N.; Yang, P.; Xing, G.; Akhtar, M.; Basit, A.; Liu, T.; Hong, C.; Arshad, M.; et al. Cellular Evidence of Exosomes in the Reproductive Tract of Chinese Soft-Shelled Turtle Pelodiscus sinensis: Identification of Exosomes in Female Turtle. J. Exp. Zool. 2017, 327, 18–27. [Google Scholar] [CrossRef] [Green Version]
  159. Nakano, S.; Yamamoto, S.; Okada, A.; Nakajima, T.; Sato, M.; Takagi, T.; Tomooka, Y. Role of extracellular vesicles in the interaction between epithelial and mesenchymal cells during oviductal ciliogenesis. Biochem. Biophys. Res. Commun. 2017, 483, 245–251. [Google Scholar] [CrossRef]
  160. Almiñana, C.; Tsikis, G.; Labas, V.; Uzbekov, R.; da Silveira, J.C.; Bauersachs, S.; Mermillod, P. Deciphering the oviductal extracellular vesicles content across the estrous cycle: Implications for the gametes-oviduct interactions and the environment of the potential embryo. BMC Genom. 2018, 19, 622. [Google Scholar] [CrossRef] [Green Version]
  161. Lopera-Vasquez, R.; Hamdi, M.; Maillo, V.; Gutierrez-Adan, A.; Bermejo-Alvarez, P.; Ramírez, M.Á.; Yáñez-Mó, M.; Rizos, D. Effect of bovine oviductal extracellular vesicles on embryo development and quality in vitro. Reproduction 2017, 153, 461–470. [Google Scholar] [CrossRef] [Green Version]
  162. Florman, H.M.; Fissore, R.A. Chapter 4—Fertilization in Mammals. In Knobil and Neill’s Physiology of Reproduction, 4th ed.; Plant, T.M., Zeleznik, A.J., Eds.; Academic Press: San Diego, CA, USA, 2015; pp. 149–196. ISBN 978-0-12-397175-3. [Google Scholar]
  163. Al-Dossary, A.A.; Bathala, P.; Caplan, J.L.; Martin-DeLeon, P.A. Oviductosome-Sperm Membrane Interaction in Cargo Delivery: Detection of Fusion and Underlying Molecular Players Using Three-Dimensional Super-Resolution Structured Illumination Microscopy (SR-SIM). J. Biol. Chem. 2015, 290, 17710–17723. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  164. Griffiths, G.S.; Galileo, D.S.; Reese, K.; Martin-DeLeon, P.A. Investigating the role of murine epididymosomes and uterosomes in GPI-linked protein transfer to sperm using SPAM1 as a model. Mol. Reprod. Dev. 2008, 75, 1627–1636. [Google Scholar] [CrossRef]
  165. Timothy Smith, T.; Nothnick, W.B. Role of Direct Contact between Spermatozoa and Oviductal Epithelial Cells in Maintaining Rabbit Sperm Viability1. Biol. Reprod. 1997, 56, 83–89. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  166. Dobrinski, I.; Timothy Smith, T.; Suarez, S.S.; Ball, B.A. Membrane Contact with Oviductal Epithelium Modulates the Intracellular Calcium Concentration of Equine Spermatozoa in Vitro1. Biol. Reprod. 1997, 56, 861–869. [Google Scholar] [CrossRef] [Green Version]
  167. Murray, S.C.; Smith, T.T. Sperm interaction with fallopian tube apical membrane enhances sperm motility and delays capacitation. Fertil. Steril. 1997, 68, 351–357. [Google Scholar] [CrossRef]
  168. Bakst, M.R.; Wishart, G.; Brillard, J.P. Oviducal sperm selection, transport, and storage in poultry. Poult. Sci. Rev. 1994, 5, 117–143. [Google Scholar]
  169. Barraud-Lange, V.; Naud-Barriant, N.; Bomsel, M.; Wolf, J.; Ziyyat, A. Transfer of oocyte membrane fragments to fertilizing spermatozoa. FASEB J. 2007, 21, 3446–3449. [Google Scholar] [CrossRef] [PubMed]
  170. Gupta, S.; Primakoff, P.; Myles, D.G. Can the presence of wild-type oocytes during insemination rescue the fusion defect of CD9 null oocytes? Mol. Reprod. Dev. 2009, 76, 602. [Google Scholar] [CrossRef]
  171. Barraud-Lange, V.; Chalas Boissonnas, C.; Serres, C.; Auer, J.; Schmitt, A.; Lefèvre, B.; Wolf, J.-P.; Ziyyat, A. Membrane transfer from oocyte to sperm occurs in two CD9-independent ways that do not supply the fertilising ability of Cd9-deleted oocytes. Reproduction 2012, 144, 53–66. [Google Scholar] [CrossRef] [Green Version]
  172. Ravaux, B.; Favier, S.; Perez, E.; Gourier, C. Egg CD9 protein tides correlated with sperm oscillations tune the gamete fusion ability in mammal. J. Mol. Cell Biol. 2018. [Google Scholar] [CrossRef]
  173. Vyas, P.; Balakier, H.; Librach, C.L. Ultrastructural identification of CD9 positive extracellular vesicles released from human embryos and transported through the zona pellucida. Syst. Biol. Reprod. Med. 2019, 65, 273–280. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  174. Jankovicova, J.; Frolikova, M.; Sebkova, N.; Simon, M.; Cupperova, P.; Lipcseyova, D.; Michalkova, K.; Horovska, L.; Sedlacek, R.; Stopka, P.; et al. Characterization of tetraspanin protein CD81 in mouse spermatozoa and bovine gametes. Reproduction 2016, 152, 785–793. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  175. Almiñana, C.; Bauersachs, S. Extracellular vesicles: Multi-signal messengers in the gametes/embryo-oviduct cross-talk. Theriogenology 2020, 150, 59–69. [Google Scholar] [CrossRef] [PubMed]
  176. Almiñana; Bauersachs Extracellular Vesicles in the Oviduct: Progress, Challenges and Implications for the Reproductive Success. Bioengineering 2019, 6, 32. [CrossRef] [PubMed] [Green Version]
  177. Ng, Y.H.; Rome, S.; Jalabert, A.; Forterre, A.; Singh, H.; Hincks, C.L.; Salamonsen, L.A. Endometrial Exosomes/Microvesicles in the Uterine Microenvironment: A New Paradigm for Embryo-Endometrial Cross Talk at Implantation. PLoS ONE 2013, 8, e58502. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  178. Greening, D.W.; Nguyen, H.P.T.; Elgass, K.; Simpson, R.J.; Salamonsen, L.A. Human Endometrial Exosomes Contain Hormone-Specific Cargo Modulating Trophoblast Adhesive Capacity: Insights into Endometrial-Embryo Interactions1. Biol. Reprod. 2016, 94, 38. [Google Scholar] [CrossRef]
  179. Burns, G.W.; Brooks, K.E.; Spencer, T.E. Extracellular Vesicles Originate from the Conceptus and Uterus During Early Pregnancy in Sheep1. Biol. Reprod. 2016, 94, 1–11. [Google Scholar] [CrossRef] [Green Version]
  180. Kropp, J.; Salih, S.M.; Khatib, H. Expression of microRNAs in bovine and human pre-implantation embryo culture media. Front. Genet. 2014, 5, 91. [Google Scholar] [CrossRef]
  181. Mellisho, E.A.; Velásquez, A.E.; Nuñez, M.J.; Cabezas, J.G.; Cueto, J.A.; Fader, C.; Castro, F.O.; Rodríguez-Álvarez, L. Identification and characteristics of extracellular vesicles from bovine blastocysts produced in vitro. PLoS ONE 2017, 12, e0178306. [Google Scholar] [CrossRef]
  182. Qu, P.; Zhao, Y.; Wang, R.; Zhang, Y.; Li, L.; Fan, J.; Liu, E. Extracellular vesicles derived from donor oviduct fluid improved birth rates after embryo transfer in mice. Reprod. Fertil. Dev. 2019, 31, 324. [Google Scholar] [CrossRef] [Green Version]
  183. Maillo, V.; Gaora, P.Ó.; Forde, N.; Besenfelder, U.; Havlicek, V.; Burns, G.W.; Spencer, T.E.; Gutierrez-Adan, A.; Lonergan, P.; Rizos, D. Oviduct-Embryo Interactions in Cattle: Two-Way Traffic or a One-Way Street?1. Biol. Reprod. 2015, 92, 144. [Google Scholar] [CrossRef] [PubMed]
  184. Pavani, K.C.; Alminana, C.; Wydooghe, E.; Catteeuw, M.; Ramírez, M.A.; Mermillod, P.; Rizos, D.; Van Soom, A. Emerging role of extracellular vesicles in communication of preimplantation embryos in vitro. Reprod. Fertil. Dev. 2017, 29, 66. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  185. Giacomini, E.; Vago, R.; Sanchez, A.M.; Podini, P.; Zarovni, N.; Murdica, V.; Rizzo, R.; Bortolotti, D.; Candiani, M.; Viganò, P. Secretome of in vitro cultured human embryos contains extracellular vesicles that are uptaken by the maternal side. Sci. Rep. 2017, 7, 5210. [Google Scholar] [CrossRef]
  186. Sheller-Miller, S.; Trivedi, J.; Yellon, S.M.; Menon, R. Exosomes Cause Preterm Birth in Mice: Evidence for Paracrine Signaling in Pregnancy. Sci. Rep. 2019, 9, 608. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  187. Kim, J.; Lee, J.; Lee, T.B.; Jun, J.H. Embryotrophic effects of extracellular vesicles derived from outgrowth embryos in pre- and peri-implantation embryonic development in mice. Mol. Reprod Dev. 2019, 86, 187–196. [Google Scholar] [CrossRef]
  188. Marin, D.; Scott, R.T. Extracellular vesicles: A promising tool for assessment of embryonic competence. Curr. Opin. Obstet. Gynecol. 2018, 30, 171–178. [Google Scholar] [CrossRef] [PubMed]
  189. Saadeldin, I.M.; Kim, S.J.; Choi, Y.B.; Lee, B.C. Improvement of Cloned Embryos Development by Co-Culturing with Parthenotes: A Possible Role of Exosomes/Microvesicles for Embryos Paracrine Communication. Cell. Reprogram. 2014, 16, 223–234. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  190. Pavani, K.; Hendrix, A.; Van Den Broeck, W.; Couck, L.; Szymanska, K.; Lin, X.; De Koster, J.; Van Soom, A.; Leemans, B. Isolation and Characterization of Functionally Active Extracellular Vesicles from Culture Medium Conditioned by Bovine Embryos In Vitro. Int. J. Mol. Sci. 2018, 20, 38. [Google Scholar] [CrossRef] [Green Version]
  191. Qu, P.; Qing, S.; Liu, R.; Qin, H.; Wang, W.; Qiao, F.; Ge, H.; Liu, J.; Zhang, Y.; Cui, W.; et al. Effects of embryo-derived exosomes on the development of bovine cloned embryos. PLoS ONE 2017, 12, e0174535. [Google Scholar] [CrossRef] [Green Version]
  192. Battaglia, R.; Palini, S.; Vento, M.E.; La Ferlita, A.; Lo Faro, M.J.; Caroppo, E.; Borzì, P.; Falzone, L.; Barbagallo, D.; Ragusa, M.; et al. Identification of extracellular vesicles and characterization of miRNA expression profiles in human blastocoel fluid. Sci. Rep. 2019, 9, 84. [Google Scholar] [CrossRef]
  193. Dissanayake, K.; Nõmm, M.; Lättekivi, F.; Ressaissi, Y.; Godakumara, K.; Lavrits, A.; Midekessa, G.; Viil, J.; Bæk, R.; Jørgensen, M.M.; et al. Individually cultured bovine embryos produce extracellular vesicles that have the potential to be used as non-invasive embryo quality markers. Theriogenology 2020, 149, 104–116. [Google Scholar] [CrossRef] [PubMed]
  194. Vilella, F.; Moreno-Moya, J.M.; Balaguer, N.; Grasso, A.; Herrero, M.; Martinez, S.; Marcilla, A.; Simon, C. Hsa-miR-30d, secreted by the human endometrium, is taken up by the pre-implantation embryo and might modify its transcriptome. Development 2015, 142, 3210–3221. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  195. Park, K.R.; Inoue, T.; Ueda, M.; Hirano, T.; Higuchi, T.; Maeda, M.; Konishi, I.; Fujiwara, H.; Fujii, S. CD9 is expressed on human endometrial epithelial cells in association with integrins α6, α3 and β1. Mol. Hum. Reprod. 2000, 6, 252–257. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  196. Domínguez, F.; Simón, C.; Quiñonero, A.; Ramírez, M.Á.; González-Muñoz, E.; Burghardt, H.; Cervero, A.; Martínez, S.; Pellicer, A.; Palacín, M.; et al. Human Endometrial CD98 Is Essential for Blastocyst Adhesion. PLoS ONE 2010, 5, e13380. [Google Scholar] [CrossRef]
  197. Wynne, F.; Ball, M.; McLellan, A.S.; Dockery, P.; Zimmermann, W.; Moore, T. Mouse pregnancy-specific glycoproteins: Tissue-specific expression and evidence of association with maternal vasculature. Reproduction 2006, 131, 721–732. [Google Scholar] [CrossRef]
  198. Liu, W.M. Tetraspanin CD9 regulates invasion during mouse embryo implantation. J. Mol. Endocrinol. 2006, 36, 121–130. [Google Scholar] [CrossRef] [Green Version]
  199. Lv, C.; Yu, W.-X.; Wang, Y.; Yi, D.-J.; Zeng, M.-H.; Xiao, H.-M. MiR-21 in extracellular vesicles contributes to the growth of fertilized eggs and embryo development in mice. Biosci. Rep. 2018, 38. [Google Scholar] [CrossRef] [Green Version]
  200. Nakamura, K.; Kusama, K.; Bai, R.; Sakurai, T.; Isuzugawa, K.; Godkin, J.D.; Suda, Y.; Imakawa, K. Induction of IFNT-Stimulated Genes by Conceptus-Derived Exosomes during the Attachment Period. PLoS ONE 2016, 11, e0158278. [Google Scholar] [CrossRef] [Green Version]
  201. Kusama, K.; Nakamura, K.; Bai, R.; Nagaoka, K.; Sakurai, T.; Imakawa, K. Intrauterine exosomes are required for bovine conceptus implantation. Biochem. Biophys. Res. Commun. 2018, 495, 1370–1375. [Google Scholar] [CrossRef]
  202. Burns, G.; Brooks, K.; Wildung, M.; Navakanitworakul, R.; Christenson, L.K.; Spencer, T.E. Extracellular Vesicles in Luminal Fluid of the Ovine Uterus. PLoS ONE 2014, 9, e90913. [Google Scholar] [CrossRef] [Green Version]
  203. Krawczynski, K.; Najmula, J.; Bauersachs, S.; Kaczmarek, M.M. MicroRNAome of Porcine Conceptuses and Trophoblasts: Expression Profile of microRNAs and Their Potential to Regulate Genes Crucial for Establishment of Pregnancy1. Biol. Reprod. 2015, 92, 21. [Google Scholar] [CrossRef] [PubMed]
  204. Bidarimath, M.; Khalaj, K.; Kridli, R.T.; Kan, F.W.K.; Koti, M.; Tayade, C. Extracellular vesicle mediated intercellular communication at the porcine maternal-fetal interface: A new paradigm for conceptus-endometrial cross-talk. Sci. Rep. 2017, 7, 40476. [Google Scholar] [CrossRef] [PubMed]
  205. Luo, S.-S.; Ishibashi, O.; Ishikawa, G.; Ishikawa, T.; Katayama, A.; Mishima, T.; Takizawa, T.; Shigihara, T.; Goto, T.; Izumi, A.; et al. Human Villous Trophoblasts Express and Secrete Placenta-Specific MicroRNAs into Maternal Circulation via Exosomes1. Biol. Reprod. 2009, 81, 717–729. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  206. Salomon, C.; Torres, M.J.; Kobayashi, M.; Scholz-Romero, K.; Sobrevia, L.; Dobierzewska, A.; Illanes, S.E.; Mitchell, M.D.; Rice, G.E. A Gestational Profile of Placental Exosomes in Maternal Plasma and Their Effects on Endothelial Cell Migration. PLoS ONE 2014, 9, e98667. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  207. Sarker, S.; Scholz-Romero, K.; Perez, A.; Illanes, S.E.; Mitchell, M.D.; Rice, G.E.; Salomon, C. Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy. J. Transl. Med. 2014, 12, 204. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  208. Redman, C.W.G.; Sargent, I.L. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J. Reprod. Immunol. 2007, 76, 61–67. [Google Scholar] [CrossRef]
  209. Baig, S.; Kothandaraman, N.; Manikandan, J.; Rong, L.; Ee, K.; Hill, J.; Lai, C.; Tan, W.; Yeoh, F.; Kale, A.; et al. Proteomic analysis of human placental syncytiotrophoblast microvesicles in preeclampsia. Clin. Proteom. 2014, 11, 40. [Google Scholar] [CrossRef] [Green Version]
  210. Pillay, P.; Maharaj, N.; Moodley, J.; Mackraj, I. Placental exosomes and pre-eclampsia: Maternal circulating levels in normal pregnancies and, early and late onset pre-eclamptic pregnancies. Placenta 2016, 46, 18–25. [Google Scholar] [CrossRef]
  211. Salomon, C.; Scholz-Romero, K.; Sarker, S.; Sweeney, E.; Kobayashi, M.; Correa, P.; Longo, S.; Duncombe, G.; Mitchell, M.D.; Rice, G.E.; et al. Gestational Diabetes Mellitus Is Associated With Changes in the Concentration and Bioactivity of Placenta-Derived Exosomes in Maternal Circulation Across Gestation. Diabetes 2016, 65, 598–609. [Google Scholar] [CrossRef] [Green Version]
  212. Kshirsagar, S.K.; Alam, S.M.; Jasti, S.; Hodes, H.; Nauser, T.; Gilliam, M.; Billstrand, C.; Hunt, J.S.; Petroff, M.G. Immunomodulatory molecules are released from the first trimester and term placenta via exosomes. Placenta 2012, 33, 982–990. [Google Scholar] [CrossRef] [Green Version]
  213. Zhang, W.; Lu, S.; Pu, D.; Zhang, H.; Yang, L.; Zeng, P.; Su, F.; Chen, Z.; Guo, M.; Gu, Y.; et al. Detection of fetal trisomy and single gene disease by massively parallel sequencing of extracellular vesicle DNA in maternal plasma: A proof-of-concept validation. BMC Med. Genom. 2019, 12, 151. [Google Scholar] [CrossRef] [PubMed]
  214. Burkova, E.E.; Dmitrenok, P.S.; Bulgakov, D.V.; Vlassov, V.V.; Ryabchikova, E.I.; Nevinsky, G.A. Exosomes from human placenta purified by affinity chromatography on sepharose bearing immobilized antibodies against CD81 tetraspanin contain many peptides and small proteins: EXOSOMES FROM HUMAN PLACENTA. IUMBM Life 2018, 70, 1144–1155. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  215. Yeung, C.H.; Cooper, T.G.; Bergmann, M.; Schulze, H. Organization of tubules in the human caput epididymidis and the ultrastructure of their epithelia. Am. J. Anat. 1991, 191, 261–279. [Google Scholar] [CrossRef]
  216. Akbarsha, M.; Faisal, K.; Radha, A. The Epididymis: Structure and Function. In Mammalian Endocrinology and Male Reproductive Biology; Singh, S., Ed.; CRC Press: Boca Raton, FL, USA, 2015; pp. 115–166. ISBN 978-1-4987-2735-8. [Google Scholar]
  217. Cornwall, G.A. New insights into epididymal biology and function. Hum. Reprod. Update 2009, 15, 213–227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  218. Gervasi, M.G.; Visconti, P.E. Molecular changes and signaling events occurring in spermatozoa during epididymal maturation. Andrology 2017, 5, 204–218. [Google Scholar] [CrossRef] [PubMed]
  219. Sullivan, R.; Mieusset, R. The human epididymis: Its function in sperm maturation. Hum. Reprod. Update 2016, 22, 574–587. [Google Scholar] [CrossRef] [Green Version]
  220. Yanagimachi, R.; Kamiguchi, Y.; Mikamo, K.; Suzuki, F.; Yanagimachi, H. Maturation of spermatozoa in the epididymis of the Chinese hamster. Am. J. Anat. 1985, 172, 317–330. [Google Scholar] [CrossRef]
  221. Fornés, M.W.; De Rosas, J.C. Interactions between rat epididymal epithelium and spermatozoa. Anat. Rec. 1991, 231, 193–200. [Google Scholar] [CrossRef]
  222. Gatti, J.-L.; Métayer, S.; Moudjou, M.; Andréoletti, O.; Lantier, F.; Dacheux, J.-L.; Sarradin, P. Prion Protein Is Secreted in Soluble Forms in the Epididymal Fluid and Proteolytically Processed and Transported in Seminal Plasma. Biol. Reprod 2002, 67, 393–400. [Google Scholar] [CrossRef] [Green Version]
  223. Rejraji, H.; Vernet, P.; Drevet, J.R. GPX5 is present in the mouse caput and cauda epididymidis lumen at three different locations. Mol. Reprod. Dev. 2002, 63, 96–103. [Google Scholar] [CrossRef]
  224. Yeung, C.-H.; Schröter, S.; Wagenfeld, A.; Kirchhoff, C.; Kliesch, S.; Poser, D.; Weinbauer, G.F.; Nieschlag, E.; Cooper, T.G. Interaction of the human epididymal protein CD52 (HE5) with epididymal spermatozoa from men and cynomolgus monkeys. Mol. Reprod. Dev. 1997, 48, 267–275. [Google Scholar] [CrossRef]
  225. Frenette, G.; Sullivan, R. Prostasome-like particles are involved in the transfer of P25b from the bovine epididymal fluid to the sperm surface. Mol. Reprod. Dev. 2001, 59, 115–121. [Google Scholar] [CrossRef] [PubMed]
  226. Girouard, J.; Frenette, G.; Sullivan, R. Compartmentalization of Proteins in Epididymosomes Coordinates the Association of Epididymal Proteins with the Different Functional Structures of Bovine Spermatozoa1. Biol. Reprod. 2009, 80, 965–972. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  227. Sullivan, R.; Saez, F. Epididymosomes, prostasomes, and liposomes: Their roles in mammalian male reproductive physiology. Reproduction 2013, 146, R21–R35. [Google Scholar] [CrossRef] [Green Version]
  228. Thimon, V.; Frenette, G.; Saez, F.; Thabet, M.; Sullivan, R. Protein composition of human epididymosomes collected during surgical vasectomy reversal: A proteomic and genomic approach. Hum. Reprod. 2008, 23, 1698–1707. [Google Scholar] [CrossRef] [Green Version]
  229. Nixon, B.; De Iuliis, G.N.; Hart, H.M.; Zhou, W.; Mathe, A.; Bernstein, I.R.; Anderson, A.L.; Stanger, S.J.; Skerrett-Byrne, D.A.; Jamaluddin, M.F.B.; et al. Proteomic Profiling of Mouse Epididymosomes Reveals their Contributions to Post-testicular Sperm Maturation. Mol. Cell Proteom. 2019, 18, S91–S108. [Google Scholar] [CrossRef] [Green Version]
  230. Caballero, J.N.; Frenette, G.; Belleannée, C.; Sullivan, R. CD9-Positive Microvesicles Mediate the Transfer of Molecules to Bovine Spermatozoa during Epididymal Maturation. PLoS ONE 2013, 8, e65364. [Google Scholar] [CrossRef] [Green Version]
  231. Sullivan, R. Epididymosomes: A heterogeneous population of microvesicles with multiple functions in sperm maturation and storage. Asian J. Androl. 2015, 17, 726–729. [Google Scholar] [CrossRef]
  232. Kirchhoff, C.; Hale, G. Cell-to-cell transfer of glycosylphosphatidylinositol-anchored membrane proteins during sperm maturation. Mol. Hum. Reprod. 1996, 2, 177–184. [Google Scholar] [CrossRef]
  233. Orlean, P.; Menon, A.K. Thematic review series: Lipid posttranslational modifications. GPI anchoring of protein in yeast and mammalian cells, or: How we learned to stop worrying and love glycophospholipids. J. Lipid Res. 2007, 48, 993–1011. [Google Scholar] [CrossRef] [Green Version]
  234. Légaré, C.; Bérubé, B.; Boué, F.; Lefièvre, L.; Morales, C.R.; El-Alfy, M.; Sullivan, R. Hamster sperm antigen P26h is a phosphatidylinositol-anchored protein. Mol. Reprod. Dev. 1999, 52, 225–233. [Google Scholar] [CrossRef]
  235. Michalková, K.; Simon, M.; Antalíková, J.; Klíma, J.; Horovská, L.; Jankovicová, J.; Hluchý, S. Identification of bovine CD52-like molecule by monoclonal antibody IVA-543: Distribution of CD52-like molecule in the bull genital tract. Theriogenology 2010, 74, 1066–1074. [Google Scholar] [CrossRef] [PubMed]
  236. Lefèvre, B.; Wolf, J.-P.; Ziyyat, A. Sperm-egg interaction: Is there a link between tetraspanin(s) and GPI-anchored protein(s)? Bioessays 2010, 32, 143–152. [Google Scholar] [CrossRef] [PubMed]
  237. de Gassart, A.; Geminard, C.; Fevrier, B.; Raposo, G.; Vidal, M. Lipid raft-associated protein sorting in exosomes. Blood 2003, 102, 4336–4344. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  238. Juyena, N.S.; Stelletta, C. Seminal Plasma: An Essential Attribute to Spermatozoa. J. Androl. 2012, 33, 536–551. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  239. Yang, C.; Guo, W.-B.; Zhang, W.-S.; Bian, J.; Yang, J.-K.; Zhou, Q.-Z.; Chen, M.-K.; Peng, W.; Qi, T.; Wang, C.-Y.; et al. Comprehensive proteomics analysis of exosomes derived from human seminal plasma. Andrology 2017, 5, 1007–1015. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  240. Rolland, A.D.; Lavigne, R.; Dauly, C.; Calvel, P.; Kervarrec, C.; Freour, T.; Evrard, B.; Rioux-Leclercq, N.; Auger, J.; Pineau, C. Identification of genital tract markers in the human seminal plasma using an integrative genomics approach. Hum. Reprod. 2013, 28, 199–209. [Google Scholar] [CrossRef] [Green Version]
  241. Höög, J.L.; Lötvall, J. Diversity of extracellular vesicles in human ejaculates revealed by cryo-electron microscopy. J. Extracell. Vesicles 2015, 4, 28680. [Google Scholar] [CrossRef] [Green Version]
  242. Alvarez-Rodriguez, M.; Ljunggren, S.A.; Karlsson, H.; Rodriguez-Martinez, H. Exosomes in specific fractions of the boar ejaculate contain CD44: A marker for epididymosomes? Theriogenology 2019, 140, 143–152. [Google Scholar] [CrossRef]
  243. Murdica, V.; Giacomini, E.; Alteri, A.; Bartolacci, A.; Cermisoni, G.C.; Zarovni, N.; Papaleo, E.; Montorsi, F.; Salonia, A.; Viganò, P.; et al. Seminal plasma of men with severe asthenozoospermia contain exosomes that affect spermatozoa motility and capacitation. Fertil. Steril. 2019, 111, 897–908. [Google Scholar] [CrossRef]
  244. Ronquist, G.; Brody, I.; Gottfries, A.; Stegmayr, B. An Mg2+ and Ca2+-Stimulated Adenosine Triphosphatase in Human Prostatic Fluid: Part I. Andrologia 1978, 10, 261–272. [Google Scholar] [CrossRef] [PubMed]
  245. Ronquist, G.; Brody, I.; Gottfries, A.; Stegmayr, B. An Mg2+ and Ca2+-Stimulated Adenosine Triphosphatase in Human Prostatic Fluid—Part II. Andrologia 1978, 10, 427–433. [Google Scholar] [CrossRef] [PubMed]
  246. Brody, I.; Ronquist, G.; Gottfries, A. Ultrastructural localization of the prostasome—An organelle in human seminal plasma. Ups. J. Med. Sci. 1983, 88, 63–80. [Google Scholar] [CrossRef]
  247. Ronquist, G.; Brody, I. The prostasome: Its secretion and function in man. Biochim. Biophys. Acta 1985, 822, 203–218. [Google Scholar] [CrossRef]
  248. Ronquist, G. Prostasomes are mediators of intercellular communication: From basic research to clinical implications: Review: Prostasomes are mediators of intercellular communication. J. Intern. Med. 2012, 271, 400–413. [Google Scholar] [CrossRef] [PubMed]
  249. Aalberts, M.; van Dissel-Emiliani, F.M.F.; van Adrichem, N.P.H.; van Wijnen, M.; Wauben, M.H.M.; Stout, T.A.E.; Stoorvogel, W. Identification of distinct populations of prostasomes that differentially express prostate stem cell antigen, annexin A1, and GLIPR2 in humans. Biol. Reprod. 2012, 86, 82. [Google Scholar] [CrossRef] [PubMed]
  250. Aalberts, M.; Sostaric, E.; Wubbolts, R.; Wauben, M.W.M.; Nolte-’t Hoen, E.N.M.; Gadella, B.M.; Stout, T.A.E.; Stoorvogel, W. Spermatozoa recruit prostasomes in response to capacitation induction. Biochim. Biophys. Acta 2013, 1834, 2326–2335. [Google Scholar] [CrossRef]
  251. Du, J.; Shen, J.; Wang, Y.; Pan, C.; Pang, W.; Diao, H.; Dong, W. Boar seminal plasma exosomes maintain sperm function by infiltrating into the sperm membrane. Oncotarget 2016, 7, 58832–58847. [Google Scholar] [CrossRef] [PubMed]
  252. Brzozowski, J.S.; Bond, D.R.; Jankowski, H.; Goldie, B.J.; Burchell, R.; Naudin, C.; Smith, N.D.; Scarlett, C.J.; Larsen, M.R.; Dun, M.D.; et al. Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion. Sci. Rep. 2018, 8, 8822. [Google Scholar] [CrossRef] [Green Version]
  253. Barranco, I.; Padilla, L.; Parrilla, I.; Álvarez-Barrientos, A.; Pérez-Patiño, C.; Peña, F.J.; Martínez, E.A.; Rodriguez-Martínez, H.; Roca, J. Extracellular vesicles isolated from porcine seminal plasma exhibit different tetraspanin expression profiles. Sci. Rep. 2019, 9, 11584. [Google Scholar] [CrossRef] [Green Version]
  254. Alvarez-Rodriguez, M.; Ntzouni, M.; Wright, D.; Khan, K.I.; López-Béjar, M.; Martinez, C.A.; Rodriguez-Martinez, H. Chicken seminal fluid lacks CD9- and CD44-bearing extracellular vesicles. Reprod. Domest. Anim. 2020, 55, 293–300. [Google Scholar] [CrossRef] [PubMed]
  255. Lötvall, J.; Hill, A.F.; Hochberg, F.; Buzás, E.I.; Di Vizio, D.; Gardiner, C.; Gho, Y.S.; Kurochkin, I.V.; Mathivanan, S.; Quesenberry, P.; et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: A position statement from the International Society for Extracellular Vesicles. J. Extracell. Vesicles 2014, 3. [Google Scholar] [CrossRef] [PubMed]
Publisher's Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Ijms 21 07568 g001 550
Figure 1. Extracellular vesicles: Their origin, size, and cargo. ESCRT-endosomal sorting complex required for transport; ALIX-protein regulating cellular mechanisms, including endocytic membrane trafficking and cell adhesion; TSG101-tumor susceptibility gene 101 protein; HSP-heat shock protein, CD-cluster of differentiation; RAB-proteins included in regulation of endocytosis and secretory processes, C3b-complement component.
Figure 1. Extracellular vesicles: Their origin, size, and cargo. ESCRT-endosomal sorting complex required for transport; ALIX-protein regulating cellular mechanisms, including endocytic membrane trafficking and cell adhesion; TSG101-tumor susceptibility gene 101 protein; HSP-heat shock protein, CD-cluster of differentiation; RAB-proteins included in regulation of endocytosis and secretory processes, C3b-complement component.
Ijms 21 07568 g001
Ijms 21 07568 g002 550
Figure 2. Illustrative schema of tetraspanin structure. Tetraspanin proteins traverse the plasma membrane (PM) four times, thus, defining the four transmembrane domains (TM1, TM2, TM3, TM4) with conserved polar residues (PRs) in their structure. In the extracellular space, the small (SEL) and large (LEL) extracellular loops can be recognized. The LEL contains a highly conserved CCG motif and possibly an additional two, four, five, six, or eight conserved cysteine residues (Cys). Between the cysteine residues, two disulfide bridges that enable folding of the LEL can be formed. Tetraspanins are post-translationally modified by glycosylation (G) in the large or small extracellular domain and palmitoylation (P) at the intracellular cysteine residues. Short N-terminal and C-terminal tails are oriented intracellularly.
Figure 2. Illustrative schema of tetraspanin structure. Tetraspanin proteins traverse the plasma membrane (PM) four times, thus, defining the four transmembrane domains (TM1, TM2, TM3, TM4) with conserved polar residues (PRs) in their structure. In the extracellular space, the small (SEL) and large (LEL) extracellular loops can be recognized. The LEL contains a highly conserved CCG motif and possibly an additional two, four, five, six, or eight conserved cysteine residues (Cys). Between the cysteine residues, two disulfide bridges that enable folding of the LEL can be formed. Tetraspanins are post-translationally modified by glycosylation (G) in the large or small extracellular domain and palmitoylation (P) at the intracellular cysteine residues. Short N-terminal and C-terminal tails are oriented intracellularly.
Ijms 21 07568 g002
Ijms 21 07568 g003 550
Figure 3. Evidenced/predicted involvement of tetraspanins in EV functions in somatic cells. EVs-extracellular vesicles, ESCRT-endosomal sorting complex required for transport; ?-predicted role.
Figure 3. Evidenced/predicted involvement of tetraspanins in EV functions in somatic cells. EVs-extracellular vesicles, ESCRT-endosomal sorting complex required for transport; ?-predicted role.
Ijms 21 07568 g003
Ijms 21 07568 g004 550
Figure 4. Schematic presentation of tetraspanins detected in extracellular vesicles within mammalian male and female reproductive systems. 1. CD9, CD63, and CD81 on EVs in follicular fluid during oocyte maturation; 2. CD9 and CD81 in EVs during fertilization; 3. CD9, CD63, and CD81 in EVs of oviductal fluid; 4. CD9-, CD63-, CD81-, and CD82-positive EVs produced by the early embryo; 5. CD9, CD63, and CD81 in EVs in the sperm reservoir in the isthmus; 6. CD63 and CD81 in EVs of blastocoel fluid; 7. CD9 and CD63 in EVs during embryo implantation; 8. CD9-, CD63-, and CD81-positive EVs in uterine fluid; 9. CD9, CD63, CD81, CD82, CD151, tetraspanin-1, tetraspanin-6, tetraspanin-8, tetraspanin-9, and tetraspanin-14 in EVs of epididymal fluid; 10. CD9, CD63, CD81, and CD151 in EVs related to prostate secretion; 11. CD9, CD63, CD81, and CD151 in EVs of semen.
Figure 4. Schematic presentation of tetraspanins detected in extracellular vesicles within mammalian male and female reproductive systems. 1. CD9, CD63, and CD81 on EVs in follicular fluid during oocyte maturation; 2. CD9 and CD81 in EVs during fertilization; 3. CD9, CD63, and CD81 in EVs of oviductal fluid; 4. CD9-, CD63-, CD81-, and CD82-positive EVs produced by the early embryo; 5. CD9, CD63, and CD81 in EVs in the sperm reservoir in the isthmus; 6. CD63 and CD81 in EVs of blastocoel fluid; 7. CD9 and CD63 in EVs during embryo implantation; 8. CD9-, CD63-, and CD81-positive EVs in uterine fluid; 9. CD9, CD63, CD81, CD82, CD151, tetraspanin-1, tetraspanin-6, tetraspanin-8, tetraspanin-9, and tetraspanin-14 in EVs of epididymal fluid; 10. CD9, CD63, CD81, and CD151 in EVs related to prostate secretion; 11. CD9, CD63, CD81, and CD151 in EVs of semen.
Ijms 21 07568 g004
Table
Table 1. List of human tetraspanin superfamily members. Data were acquired from the UniProt database (UniProt Consortium. (2019). UniProt: A worldwide hub of protein knowledge. Nucleic acids research, 47(D1), D506-D515).
Table 1. List of human tetraspanin superfamily members. Data were acquired from the UniProt database (UniProt Consortium. (2019). UniProt: A worldwide hub of protein knowledge. Nucleic acids research, 47(D1), D506-D515).
Protein NameAlternative Name (s)Gene Name
Tetraspanin-1Tetraspan NET-1 (neuroepithelial cell-transforming gene 1 protein), Tetraspanin TM4-CTSPAN1
Tetraspanin-2Tetraspan NET-3TSPAN2
Tetraspanin-3Tetraspanin TM4-A, Transmembrane 4 superfamily member 8TSPAN3
Tetraspanin-4Novel antigen 2 (NAG-2), Transmembrane 4 superfamily member 7TSPAN4
Tetraspanin-5Tetraspan NET-4, Transmembrane 4 superfamily member 9TSPAN5
Tetraspanin-6A15 homologue, Putative NF-kappa-B-activating protein 321, T245 protein, Tetraspanin TM4-D, Transmembrane 4 superfamily member 6TSPAN6
Tetraspanin-7Cell surface glycoprotein A15, Membrane component chromosome X surface marker 1, T-cell acute lymphoblastic leukemia-associated antigen 1 (TALLA-1), Transmembrane 4 superfamily member 2, CD231TSPAN7
Tetraspanin-8Transmembrane 4 superfamily member 3, Tumor-associated antigen CO-029TSPAN8
Tetraspanin-9Tetraspan NET-5TSPAN9
Tetraspanin-10OCULOSPANINTSPAN10
Tetraspanin-11-TSPAN11
Tetraspanin-12Tetraspan NET-2, Transmembrane 4 superfamily member 12TSPAN12
Tetraspanin-13Tetraspan NET-6, Transmembrane 4 superfamily member 13TSPAN13
Tetraspanin-14DC-TM4F2, Transmembrane 4 superfamily member 14TSPAN14
Tetraspanin-15Tetraspan NET-7, Transmembrane 4 superfamily member 15TSPAN15
Tetraspanin-16Tetraspanin TM4-B, Transmembrane 4 superfamily member 16TSPAN16
Tetraspanin-17F-box only protein 23, Tetraspan protein SB134, Transmembrane 4 superfamily member 17TSPAN17
Tetraspanin-18-TSPAN18
Putative tetraspanin-19-TSPAN19
Uroplakin-1b (UP1b)Tetraspanin-20 (Tspan-20)UPK1B
Uroplakin-1a (UP1a, UPKa)Tetraspanin-21 (Tspan-21)UPK1A
Peripherin-2Retinal degeneration slow protein, Tetraspanin-22 (Tspan-22)PRPH2
Rod outer segment membrane protein 1 (ROSP1)Tetraspanin-23 (Tspan-23)ROM1
CD151 antigenCD151, GP27, Membrane glycoprotein SFA-1, Platelet-endothelial tetraspan antigen 3 (PETA-3), Tetraspanin-24 (Tspan-24)CD151
Leucocyte surface antigen CD53CD53, Cell surface glycoprotein CD53, Tetraspanin-25 (Tspan-25)CD53
Leucocyte antigen CD37CD37, Tetraspanin-26 (Tspan-26)CD37
CD82 antigenCD82, C33 antigen, IA4, Inducible membrane protein R2, Metastasis suppressor Kangai-1, Suppressor of tumorigenicity 6 protein, Tetraspanin-27 (Tspan-27)CD82
CD81 antigenCD81, 26 kDa cell surface protein TAPA1, Tetraspanin-28 (Tspan-28), Target of the antiproliferative antibody 1CD81
CD9 antigenCD9, 5H9 antigen, Cell growth-inhibiting gene 2 protein, Leukocyte antigen MIC3, Motility-related protein (MRP-1), p24, Tetraspanin-29 (Tspan-29)CD9
CD63 antigenCD63, Granulophysin, Lysosomal-associated membrane protein 3 (LAMP-3), Melanoma-associated antigen ME491, OMA81H, Ocular melanoma-associated antigen, Tetraspanin-30 (Tspan-30)CD63
Tetraspanin-31 (Tspan-31)Sarcoma-amplified sequenceTSPAN31
Tetraspanin-32 (Tspan-32)Protein PhemxTSPAN32
Tetraspanin-33 (Tspan-33)Penumbra (hPen), Proerythroblast new membraneTSPAN33

Share and Cite

MDPI and ACS Style

Jankovičová, J.; Sečová, P.; Michalková, K.; Antalíková, J. Tetraspanins, More than Markers of Extracellular Vesicles in Reproduction. Int. J. Mol. Sci. 2020, 21, 7568. https://doi.org/10.3390/ijms21207568

AMA Style

Jankovičová J, Sečová P, Michalková K, Antalíková J. Tetraspanins, More than Markers of Extracellular Vesicles in Reproduction. International Journal of Molecular Sciences. 2020; 21(20):7568. https://doi.org/10.3390/ijms21207568

Chicago/Turabian Style

Jankovičová, Jana, Petra Sečová, Katarína Michalková, and Jana Antalíková. 2020. "Tetraspanins, More than Markers of Extracellular Vesicles in Reproduction" International Journal of Molecular Sciences 21, no. 20: 7568. https://doi.org/10.3390/ijms21207568

APA Style

Jankovičová, J., Sečová, P., Michalková, K., & Antalíková, J. (2020). Tetraspanins, More than Markers of Extracellular Vesicles in Reproduction. International Journal of Molecular Sciences, 21(20), 7568. https://doi.org/10.3390/ijms21207568

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop